Grycová, Lenka. Applications of NMR to study structures of natural compounds. PhD thesis, Masaryk University, 2010. http://is.muni.cz/th/12679/prif_d/PhD_thesis_LG.pdf.
Guittat, L., et al. Interactions of cryptolepine and neocryptolepine with unusual DNA structures. Biochemie 85, no. 5 (2003): 535–47.
Hadden, C. E., et al. 11-isopropylcryptolepine: a novel alkaloid isolated from Cryptolepis sanguinolenta characterized using submicro NMR techniques. J Nat Prod 62, no. 2 (1999): 238–40.
Humenuik, R., et al. Cytotoxicity and cell cycle effects of novel indolo[2,3-b]quinoline derivatives. Oncol Res 13, no. 5 (2003): 269–77.
Iwu, Maurice M. The Associate Program on Ethnobiology, Socio-Economic Value Assessment and Community Based Conservation. Report DAMD17-99-2-9025, prepared for the U.S. Army Medical Research and Materiel Command, Fort Detrick, Md., October 2000. http://www.dtic.mil/cgi-bin/GetTRDoc?Location=U2&doc=GetTRDoc.pdf&AD=ADA406251.
Jansen, P. C. M., and Schmelzer, G. H. Cryptolepis sanguinoleta (Lindl.) Schltr. Record from Protabase database, ed. G. J. H. Grubben and O. A. Denton (PROTA: Plant Resources of Tropical Africa/Resources végétales de l’Afrique tropicale). Wageningen, Netherlands. http://database.prota.org/search.htm (accessed November 18, 2010).
Jaromin, A., et al. Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b] quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells. Drug Deliv 15, no. 1 (2008): 49–56.
Jonckers, T. H., et al. Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem 45, no. 16 (2002): 3497–508.
Kaul, A., et al. Immunopotentiating properties of Cryptolepis buchanani root extract. Phytother Res 17, no. 10 (2003): 1140–44.
Laupattarakasem, P., et al. An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis. J Ethnopharmacol 85, no. 2–3 (2003): 207–15.
Laupattarakasem, P., et al. In vitro and in vivo anti-inflammatory potential of Cryptolepis buchanani. J Ethnopharmacol 108, no. 3 (2006): 349–54.
Luo, J., et al. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabet Med 15, no. 5 (1998): 367–74.
Luo, J., et al. Hypoglycemic agent from cryptolepis. U.S. Patent 5,629,319, filed June 6, 1995, and issued May 13, 1997.
Maurya, et al. Pharmaceutical composition comprising extract from plant Cryptolepis buchanani for tea. U.S. Patent 6,548,086, filed December 18, 2001, and issued April 15, 2003.
Mills-Robertson, F. C., et al. In vitro antimicrobial activity of Cryptolepis sanguinolenta (Periplocaceae). Afr J Pharm Pharmacol 3, no. 10 (2009): 476–80.
Mtshemla, Vathiswa. Synthesis of 2,3-diaryl-4-methoxyquinolines via palladium-catalyzed cross coupling reactions. Master’s thesis, University of South Africa, May 2008. http://uir.unisa.ac.za/bitstream/handle/10500/2275/dissertation.pdf?sequence=1.
Noamesi, B. K., et al. Studies on cryptolepine. Planta Med 48, no. 5 (1983): 48–51.
Obua, C., et al. Antimalarial activity of some plants used in traditonal medicine in Uganda. E C Afr J Pharma Sci 5, no. 2 (2002): 1.
Olajide, O. A., et al. Anti-inflammatory properties of cryptolepine. Phytother Res 23, no. 10 (2009): 1421–25.
Olajide, O. A., et al. Synthetic cryptolepine inhibits DNA binding of NF-kappaB. Bioorg Med Chem 15, no. 1 (2007): 43–49.
Oluwafemi, A. J., et al. Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis. Nat Prod Commun 4, no. 2 (2009): 193–98.
Otsyina, Hope R. Toxicological evaluation of Cryptolepis sanguinolenta, Momordica charantia and Euphorbia hirta in rats. Thesis, Kwame Nkruma University of Science and Technology (Ghana), 2008. http://dspace.knust.edu.gh:8080/jspui/handle/123456789/885.
Oyekan, A. O., et al. Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivo. Gen Pharmacol 19, no. 2 (1988): 233–37.
Pande, M., et al. Crystalization and preliminary X-ray analysis of cryptolepain, a novel glycosylated serine protease from Cryptolepis buchanani. Acta Crystallogr Sect F Struct Biol Cryst Commun 63, part 2 (2006): 74–80.
Paulo, A., et al. Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. Planta Med 66, no. 1 (2000): 30–34.
Paulo, A., et al. Chemotaxonomic analysis of the genus Cryptolepis. Biochem Syst Ecol 31, no. 2 (2003): 155–66.
Paulo, A., et al. Cryptolepis sanguinolenta activity against diarrhoeal bacteria. J Ethnopharmacol 44, no. 2 (1994): 73–77.
Paulo, A., et al. In vitro antibacterial screening of Cryptolepis sanguinolenta alkaloids. J Ethnopharmacol 44, no. 2 (1994): 127–30.
Paulo, A., et al. Steroidal alkaloids from Cryptolepis obtusa. Phytochemistry 53, no. 3 (2000): 417–22.
Prasad, P. J. N., et al. Micropropagation of Cryptolepis buchanani Roem. & Schult. Taiwania 49, no. 1 (2004): 57–65.
Rao, V. R., et al. Interactions of cryptosin with mammalian cardiac beta-adrenoceptors. Drug Chem Toxicol 13, no. 2–3 (1990): 173–94.
Rauwald, H. W., et al. Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors. Planta Med 58, no. 6 (1992): 486–88.
Sawer, I. K., et al. The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae. J Appl Bacteriol 79, no. 3 (1995): 314–21.
Sawer, I. K., et al. The killing effect of cryptolepine on Staphylococcus aureus. Lett Appl Microbiol 40, no. 1 (2005): 24–29.
Silva, O., et al. Antimicrobial activity of Guinea-Bissau traditional remedies. J Ethnopharmacol 50, no. 1 (1996): 55–59.
Simon, J. E., et al. Medicinal crops of Africa. In Issues in new crops and new uses, ed. J. Janick and A. Whipkey, 322–31. Alexandria, Va.: ASHS Press, 2007. http://hort.purdue.edu/newcrop/ncnu07/pdfs/simon322-331.pdf.
Sittiwet, C., et al. Anti-bacterial activity of Cryptolepis buchanani aqueous extract. Int J Biol Chem 3 (2009): 90–94.
Soh, P. N., et al. Are West African plants a source of future antimalarial drugs? J Ethnopharmacol 114, no. 2 (2007): 130–40.
Tempesta, Michael S. The clinical efficacy of Cryptolepis sanguinolenta in the treatment of malaria. Ghana Med J 44, no. 1 (2010): 1–2.
Van Miert, S., et al. In vitro inhibition of beta-haematin formation, DNA interactions, neocryptolepine derivatives. Exp Parasitol 108, no. 3–4 (2004): 163–68.
Van Miert, S., et al. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound. J Nat Prod 68, no. 5 (2005): 674–77.
Venkateswara, R., et al. Cryptosin, a cardenolide from the leaves of Cryptolepis buchanani. Phytochemistry 28, no. 4 (1989): 1203–5.
Wright, C. W. Cryptolepine and development of new antimalarial agents. Iran J Pharm Res (IJPR) 3, suppl. 2 (2004): 17.
Wright, C. W. Recent developments in naturally derived antimalarials: cryptolepine analogues. J Pharm Pharmacol 59, no. 6 (2007): 899–904.
Yakubu, Clare Banoeng. “Nibima”: a wonder plant for malaria treatment for Ghana. Eyes on Malaria 3 (online). http://eyesonmalaria.org/nibima.html.
Yeau, K. L., et al. The cardiotonic effect of a glycoside from Cryptolepis buchanani. Yao Xue Xue Bao 10 (1963): 561–65.
Zhu, H., et al. Chemical compound review: cymopol. Entry on WikiGenes website at http://wikigenes.org/e/chem/e/5386672.html (accessed November 18, 2010).
Zhu, H., et al. Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells. Oxford J Life Sci Med Tox Sci 91, no. 1 (2006): 132–39.
Zhu, X. Y., et al. Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antinfective agents. Bioorg Med Chem 15, no. 2 (2007): 686–95.
Aboulella, A. M., et al. Phytotherapeutic effects of Echinacea purpurea in gamma-irradiated mice. J Vet Sci 8, no. 4 (2007): 341–51.
Anonymous. Echinacea: Monograph. Altern Med Rev 6, no. 4 (2001): 411–14.
Binns, S. E., et al. Light-mediated antifungal activity of echinacea extracts. Planta Med 66, no. 3 (2000): 241–14.
Birt, D. F. Echinacea in infection. Am J Clin Nutr 87, no. 2 (2008): 488S–92S.
Brush, J., et al. The effect of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell activation in humans. Phytother Res 20, no. 8 (2006): 687–95.
Chaves, Fernando., et al. Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to Bothrops asper venom and immune cell response. Rev Biol Trop Int J Trop Biol 55, no. 1 (2007): 113–19.
Facino, R. M., et al. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of echinacea extracts in the prevention of skin photodamage. Planta Med 61, no. 6 (1995): 510–14.
Fuchikama, H., et al. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 34, no. 4 (2006): 577–82.
Jurkstiene, V., et al. Compensatory reactions of immune sytem and action of purple coneflower (Echinacea purpurea (L.) Moench) preparations. Medicina (Kaunas) 40, no. 7 (2004): 657–62.
Kim, L. S., et al. Immunological activity of larch arabinogalactan and echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 7, no. 2 (2002): 138–49.
Kraus, G. A., et al. Synthesis and natural distribution of anti-inflammatory alkamides from echinacea. Molecule 11, no. 10 (2006): 758–67.
LaLone, C. A., et al. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells. J Agric Food Chem 55, no. 18 (2007): 7314–22.
Lee, T.-T., et al. Flavonoid, phenol and polysaccharide content of Echinacea purpurea L. and its immunostimulant capacity in vitro. Internl J Enviro Sci Dev 1, no. 1 (2010): 5–9.
McCann, D. A., et al. Cytokine- and interferon-modulating properties of Echinacea spp. root tinctures stored at –20 degrees C for 2 years. J Interferon Cytokine Res 27, no. 5 (2007): 425–36.
Melchart, D., et al. Results of five randomized studies on the immunomodulatory activity of preparations of echinacea. J Altern Complement Med 1, no. 2 (1995): 145–60.
Miller, Sandra C. Echinacea: a miracle herb against aging and cancer? Evidence in vivo in mice. Evid Based Complement Alternat Med 2, no. 3 (2005): 309–14.
Mishima, S., et al. Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull 27, no. 7 (2004): 1004–9.
Pleschka, S., et al. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H5N7) and swine-origin H1N1 (S-OIV). Virol J 13, no. 6 (2009): 197.
Raduner, S., et al. Alkylamides from echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem 281, no. 20 (2006): 14192–206.
Rininger, J. A., et al. Immunopharmacological activity of echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J Leukocyt Biol 68 (2000): 503.
Roesler, J., et al. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmacol 13, no. 1 (1991): 27–37.
Romiti, N., et al. P-glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line. Planta Med 74, no. 3 (2008): 264–66.
Rousseau, B., et al. Investigation of anti-hyaluronidase treatment on vocal fold wound healing. J Voice 20, no. 3 (2006): 443–51.
Senchina, D. S., et al. Phenetic comparison of seven echinacea species based on immunomodulatory characteristics. Econ Bot 60, no. 3 (2006):205–11.
Senchina, D. S., et al. Year-and-a-half old, dried echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination. Planta Med 72, no. 13 (2006): 1207–15.
Sharma, M., et al. The potential use of echinacea in acne: control of Propionibacterium acnes growth and inflammation. Phytother Res 25, no. 4 (2011): 517–21. E-pub (preprint) September 9, 2010.
Sharma, S. M., et al. Bactericidal and anti-inflammatory properties of a standardized echinacea extract (Echinaforce): dual actions against respiratory bacteria. Phytomedicine 17, no. 8–9 (2010): 563–68.
Soudi, S., et al. Antileishmanial effect of Echinacea purpurea root extract cultivated in Iran. Iran J Pharm Res 6, no. 2 (2007): 147–49.
Spence, Katherine M. In vivo evaluation of immunomodulatory properties of crude extracts of Echinacea species and fractions isolated from Echinacea purpurea. Master’s thesis, University of Southern Queensland (Toowoomba, Queensland), 1999. http://eprints.usq.edu.au/1512/.
Steinmüller, C., et al. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 15, no. 5 (1993): 605–14.
Stevenson, L. M., et al. Modulation of macrophage immune responses by echinacea. Molecules 10 (2005): 1279–85.
Tamta, H., et al. Variability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharides. J Agric Food Chem 56, no. 22 (2008): 10552–56.
Tunnerhoff, F. H., et al. Research in man and animal on the effect of echinacea extracts on artificial formation of connective tissues after fibrin implantations. Arzneimittelforschung 6, no. 6 (1956): 330–34.
Wagner, H., et al. Immunostimulant action of polysaccharides (heteroglycans) from higher plants. Preliminary communication. Arzneimittelforschung 34, no. 6 (1984): 659–61.
Wagner, H., et al. Immunostimulating action of polysaccharides (heteroglycans) from higher plants. Arzneimittelforschung 35, no. 7 (1985): 1069–75.
Wang, C. Y., et al. Genomics and proteomics of immune modulatory effects of a butanol fraction of Echinacea purpurea in human dendritic cells. BMC Genomics 13, no. 9 (2008): 479.
Zaporozhets, O. A., et al. Medicinal plants: spectrophotometric determination of hydroxycynnamic acid and related compounds in echinacea preparations. Pharmaceutical Chem J 37, no. 12 (2003): 632.
Zhai, Z., et al. Alcohol extract of Echinacea pallida reverses stress-delayed wound healing in mice. Phytomedicine 16, no. 6–7 (2009): 669–78.
Zhai, Z., et al. Alcohol extracts of echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro. Food Agric Immunol 18, no. 3–4 (2007): 221–36.
Zhai, Z., et al. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. J Ethnopharmacol 122, no. 1 (2009): 76–85.
Zhai, Z., et al. Enhancement of innate and adaptive immune functions by multiple Echinacea species. J Med Food 10, no. 3 (2007): 423–34.
Zwickey, H., et al. The effects of Echinacea purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD25 expression in humans: a pilot study. Phytother Res 21, no. 11 (2007): 1109–12.
Anonymous. Eleutherococcus. Wikipedia. http://en.Wikipedia.org/wiki/Eleutherococcus (accessed December 9, 2010).
Anonymous. Eleutherococcus pentaphyllus. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=ELPE6 (accessed 12/9/2010).
Anonymous. Eleutherococcus senticosus. Entry in the Plants for a Future database. http://pfaf.org/user/Plant.aspx?LatinName=Eleutherococcus+senticosus (accessed January 24, 2008).
Anonymous. Eleutherococcus senticosus. Wikipedia. http://en.Wikipedia.org/wiki/Eleutherococcus_senticosus (accessed December 9, 2010).
Anonymous. Eleutherococcus senticosus: monograph. Altern Med Rev 11, no. 2 (2006): 151–55.
Anonymous. Ginseng: Eleutherococcus pentaphyllus. State distribution map on the website of EDDMApS (Early Detection and Distribution Mapping System) at http://eddmaps.org/distribution/usstate.cfm?sub=21019 (accessed December 9, 2010).
Arushanian, E. B., et al. Effect of eleutherococcus on short-term memory and visual perception in healthy humans. Eksp Klin Farmakol 66, no. 5 (2003): 10–13.
Baczek, Katarzyna. Accumulation of biologically active compounds in eleuthero (Eleutherococcus senticosus/Rupr. Et Maxim./Maxim.) grown in Poland. Herba Polonica 55, no. 1 (2009): 7–13.
Barenboim, G. M. Part V: Eleutherococcus and adaptogens: generalizations and hypotheses. Eleutherococcus: application and the mechanism of action. Available online on the website of VitaOffice at http://vitaoffice.com/images/office/download/eleuthroandadaptogens.pdf (accessed December 19, 2011).
Barenboim, G. M., and N. B. Kozlova. Part III: Eleutherococcus extract as an agent increasing the biological resistance of man exposed to unfavorable factors. Use of eleutherococcus extract for increasing the biological resistance of man exposed to different unfavourable environmental factors (a review). Available online on the website of VitaOffice at http://vitaoffice.com/images/office/download/eleuthrobioresist.pdf (accessed December 19, 2011).
Barenboim, G. M., and L. A. Protozanova. Part IV: Eleutherococcus extract: prospective trends in application. General methodological principles of the use of eleutherococcus extract for decreasing the effects of embryotoxic factors. Available online on the website of VitaOffice at http://vitaoffice.com/images/office/download/eleuthrotrends.pdf (accessed December 19, 2011).
Bocharov, E. V., et al. Neuroprotective features of phytoadaptogens. Vestn Ross Akad Med Nauk 4 (2008): 47–50.
Cicero, A. F., et al. Effects of Siberian ginseng (Eleutherococcus senticosus Maxim.) on elderly quality of life: a randomized clinical trial. Arch Gerentol Geriatr Suppl 9 (2004): 69–73.
Dardymov, I. V. Part II: Study of the mechanism of action of eleutherococcus extract. Some aspects of the mechanism of action of eleutherococcus extract. Available online on the website of VitaOffice at http://vitaoffice.com/images/office/download/eleuthromechanism.pdf (accessed December 19, 2011).
Davydov, M., et al. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol 72, no. 3 (2000): 345–93.
Deyama, T., et al. Constituents and pharmacological effects of Eucommia and Siberian ginseng, Acta Pharmacol Sin 22, no. 12 (2001): 1057–70.
Donovan, J. L., et al. Siberian ginseng (Eleutherococcus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 31, no. 5 (2003): 519–22.
Drozd, J., et al. Estimation of humoral activity of Eleutherococcus senticosus. Acta Pol Pharm 59, no. 9 (2002): 395–401.
Feng, S., et al. Determination of eleutheroside E and eleutheroside B in rat plasma and tissue by high-performance liquid chromatography using solid-phase extraction and photodiode array detection. Eur J Pharm Biopharm 62, no. 3 (2006): 315–20.
Gaffney, B. T., et al. The effects of Eleutherococcus senticosus and Panax ginseng on steroidal hormone indices of stress and lymphocyte subset numbers in endurance athletes. Life Sci 70, no. 4 (2001): 431–42.
Gaffney, B. T., et al. Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors. Med Hypotheses 56, no. 5 (2001): 567–72.
Glatthaar-Saalmüller, B., et al. Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiviral Res 50, no. 3 (2001): 223–28.
Hartz, A. J., et al. Randomized controlled trial of Siberian ginseng for chronic fatigue. Psychol Med 34, no. 1 (2004): 51–61.
Jeong, H. J., et al. Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian ginseng. Immunopharmacol Immunotoxicol 23, no. 1 (2001): 107–17.
Jung, C. H., et al. Eleutherococcus senticosus extract attenuates LPS-induced iNOS expression through the inhibition of Akt and JNK pathways in murine macrophage. J Ethnopharmacol 113, no. 1 (2007): 183–87.
Kang, J. S., et al. Quantitative determination of eleutheroside B and E from Acanthopanax species by high performance liquid chromatography. Arch Pharm Res 24, no. 5 (2001): 407–11.
Kaplan, E. Y., et al. Part I: Eleutherococcus extract. Action range study of the range of the adaptogenic action of Eleutherococcus senticosus Rupr. et Maxim. Available online on the website of VitaOffice at http://vitaoffice.com/images/office/download/eleuthroactionrange.pdf (accessed December 19, 2011).
Kimura, Y., et al. Effects of various Eleutherococcus senticosus cortex on swimming time, natural killer activity and corticosterone level in forced swimming stressed mice. J Ethnopharmacol 95, no. 2–3 (2004): 447–53.
Kuo, J., et al. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. Chin J Physiol 53 (2010): 1–7.
Lee, Jung J., et al. Extract of Acanthopanax koreanum for the treatment or prevention of hepatitis or the liver protective drug. U.S. Patent 7,309,504 B2, filed January 24, 2003, and issued December 18, 2007.
Lee, S., et al. Antiinflammatory activity of hyperin from Acanthopanax chiisanensis roots. Arch Pharm Res 27, no. 6 (2004): 628–32.
Li, W., et al. Acanthopanax for acute ischemic stroke. Cochrane Database Syst Rev 8, no. 3 (2009): CD007032.
Liu, Y, et al. Effects of Acanthopanax giraldii Harms var. hispidus Hoo polysaccharides on the human gastric cancer cell line SGC-7901 and its possible mechanism. Chin Med J 115, no. 5 (2002): 716–21.
Natural Products Research Institute at Seoul National University. Eleutherococcus sessiliflorus. In Medicinal plants in the Republic of Korea. WHO Regional Publications Western Pacific Series, no. 21. Manila: World Health Organization, 1998. http://wpro.who.int/internet/files/pub/97/105.pdf.
Panossian, A., et al. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration. Phytother Res 19, no. 10 (2005): 819–38.
Park, H. R., et al. Antioxidant activity of extracts from Acanthopanax senticosus. Afr J Biotechnol 5, no. 23 (2006): 2388–96.
Provalova, N. V., et al. Mechanisms underling the effects of adaptogens on erythropoiesis during paradoxical sleep deprivation. Bull Exp Biol Med 133, no. 5 (2002): 428–32.
Randall, R. P. Eleutherococcus pentaphyllus (Araliaceae). Entry in A Global Compendium of Weeds. Meredith, Victoria (Australia): R. G. and F. J. Richardson, 2002. Available on the website of the Hawaiian Ecosystems at Risk (HEAR) project at http://hear.org/gcw/species/eleutherococcus_pentaphyllus (accessed December 9, 2010).
Rogala, E., et al. The influence of Eleutherococcus senticosus on cellular and humoral immunological response of mice. Pol J Vet Sci 6, no. 3, suppl. (2003): 37–39.
Sang-Chul, J., et al. Chemical characteristics and immuno-stimulating properties of biopolymers extracted from Acanthopanax sessiliflorus. J Biochem Mol Biol 39, no. 1 (2006): 84–90.
Schmolz, M. W., et al. The synthesis of Rantes, G-CSF, IL-4, IL-5, IL-6, IL-12 and IL-13 in human whole-blood cultures is modulated by an extract from Eleutherococcus senticosus L. roots. Phytother Res 15, no. 3 (2001): 268–70.
Singh, N., et al. A comparative evaluation of some anti-stress agents of plant origin. Ind J Pharmacol 23, no. 2 (1991): 99–103.
Singh, N., et al. Effect of anti-stress plants on biochemical changes during stress reaction. Ind J Pharmacol 23, no. 3 (1991): 137–42.
Sithisarn, P., et al. Antioxidant activity of Acanthopanax trifoliatus. Med Princ Pract 18 (2009): 393–98.
Soya, H., et al. Extract from Acanthopanax senticosus Harms (Siberian ginseng) activates NTS and SON/PVN in the rat brain. Biosci Biotechnol Biochem 72, no. 9 (2008): 2467–80.
Steinmann, G. G., et al. Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts. Arzneimittelforschung 51, no. 1 (2001): 76–83.
Szolomicki, J., et al. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in man. Phytother Res 14, no. 1 (2000): 30–35.
Tohda, C., et al. Inhibitory effects of Eleutherococcus senticosus extracts on amyloid beta(25-35)-induced neuritic atrophy and synaptic loss. J Pharmacol Sci 107, no. 3 (2008): 329–39.
Wang, Z., et al. Semipreparative separation and determination of eleutheroside E in Acanthopanax giraldii Harms by high-performance liquid chromatography. J Chromatogr Sci 43, no. 5 (2005): 249–52.
Weigant, F. A., et al. Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology 10, no. 1 (2009): 27–42.
Yi, J. M, et al. Effect of Acanthopanax senticosus stem on mast cell-dependent anaphylaxis. J Ethnopharmacol 79, no. 3 (2002): 347–52.
Yunfei, Deng. Eleutherococcus humillimus, a new combination in Chinese Araliaceae. Novon 13 (2003): 305–6.
Ahui, M. L., et al. Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation. Int Immunopharmacol 8, no. 12 (2008): 1626–32.
Ajith, T. A., et al. Zingiber officinale Roscoe prevents acetaminophen-induced acute hepatotoxicity by enhancing hepatic antioxidant status. Food Chem Toxicol 45, no. 11 (2007): 2267–72.
Altman, R. D., et al. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 44, no. 11 (2001): 2531–38.
Anonymous. Ginger. Herbs at a Glance fact sheet from the U.S. National Center for Complementary and Alternative Medicine, updated July 2010. http://nccam.nih.gov/health/ginger/.
Anonymous. Ginger. Profile on the website Herbs2000.com. http://herbs2000.com/herbs/herbs_ginger.htm (accessed February 9, 2011). Anonymous. Ginger. Wikipedia. http://en.wikipedia.org/wiki/Ginger (accessed February 9, 2011).
Benchaluk, T., et al. Effects of Zingiber officinale Roscoe on methyl parathion intoxication in rats. Chinag Mai Med J 49, no. 3 (2010): 81–88.
Bensch, K., et al. Investigations into the antiadhesive activity of herbal extracts against Campylobacter jejuni. Phytother Res 25, no. 8 (2011): 1125–32. E-pub (preprint) January 31, 2011.
Betoni, J. E., et al. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem Inst Oswaldo Cruz 101, no. 4 (2006): 387–90.
Betz, O., et al. Is ginger a clinically relevant antiemetic? A systematic review of randomized controlled trials. Forsch Komplementarmed Klass Naturheilkd 12, no. 1 (2005): 14–23.
Bhat, J., et al. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother Res 24, no. 1 (2010): 129–35.
Black, C. D., et al. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. J Pain 11, no. 9 (2010): 894–903.
Borrelli, F., et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105, no. 4 (2005): 849–56.
Carrasco, F. R., et al. Immunomodulatory activity of Zingiber officinale Roscoe, Salvia officinalis L. and Syzygium aromaticum L. essential oils: evidence for humor- and cell-mediated responses. J Pharm Pharmacol 61, no. 7 (2009): 961–67.
Chen, I. N., et al. Antioxidant and antimicrobial activity of Zingiberaceae plants in Taiwan. Plant Foods Hum Nutr 63, no. 1 (2008): 15–20.
Cwikla, C., et al. Investigations into the antibacterial activities of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni. Phytother Res 24, no. 5 (2010): 649–56.
Daswani, P. G., et al. Antidiarrhoeal activity of Zingiber officinale (Rosc.). Current Sci 98, no. 2 (2010): 222–29,.
Datta, A., et al. Antifilarial effect of Zingiber officinale on Dirofilaria immitis. J Helminthol 61, no. 3 (1987): 268–70.
Demin, G., et al. Comparative antibacterial activities of crude polysaccharides and flavonoids from Zingiber officinale and their extraction. Asian J Trad Med 5, no. 6 (2010): 1.
Denyer, C. V., et al. Isolation of antirhinoviral sesquiterpenes from ginger (Zingiber officinale). J Nat Prod 57, no. 5 (1994): 658–62.
Dügenci, S. K., et al. Some medicinal plants as immunostimulant for fish. J Ethnopharmacol 88, no. 1 (2003): 99–106.
Egwurugwa, J. N., et al. Effects of ginger (Zingiber officinale) on cadmium toxicity. Afr J Biotechnol 6, no. 18 (2007): 2078–82.
Fischer-Rasmussen, W., et al. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol 38, no. 1 (1991): 19–24.
Foster, Steven. Ginger: Zingiber officinale—your food is your medicine. Monograph on the website of Steven Foster. http://stevenfoster.com/education/monograph/ginger2.html (accessed February 9, 2011).
Gato, C., et al. Lethal efficacy of extract from Zingiber officinale (traditional Chinese medicine) or [6]-shogaol and [6]-gingerol in Anisakis larvae in vitro. Parasitol Res 76, no. 8 (1990): 653–56.
Gaus, K., et al. Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagA Helicobacter pylori. Pharm Biol 47, no. 1 (2009): 92–98.
Ginger, C. D. Molecular/biochemical development of new drugs against macro- and microfilariae. Acta Leiden 59, no. 1–2 (1990): 315–28.
Haghighi, M., et al. Comparing the effects of ginger (Zingiber officinale) extract and ibuprofen on patients with osteoarthritis. Arch Iran Med 8, no. 4 (2005): 267–71.
Heeba, G. H., et al. Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. Phytomedicine 17, no. 14 (2010): 1076–81.
Imanishi, N., et al. Macrophage-mediated inhibitory effect of Zingiber officinale Rosc, a traditional Oriental herbal medicine, on the growth of influenza A/Aichi/2/68 virus. Am J Cin Med 34, no. 1 (2006): 157–69.
Immanuel, G., et al. Dietary medicinal plant extracts improve growth, immune activity and survival of tilapia Oreochromis mossambicus. J Fish Biol 74, no. 7 (2009): 1462–75.
Iqbal, Z., et al. In vitro anthelmintic activity of Allium sativum, Zingiber officinale, Cucurbita mexicana and Ficus religiosa. Int J Agr Biol 3, no. 4 (2001).
Iqbal, Z., et al. In vivo anthelmintic activity of ginger against gastrointestinal nematodes of sheep. J Ethnopharmacol 106, no. 2 (2006): 285–87.
Iwami, M., et al. Inhibitory effects of zingerone, a pungent component of Zingiber officinale Roscoe, on colonic motility in rats. J Nat Med 65, no. 1 (2011): 89–94.
Jagetia, G. C., et al. Influence of ginger rhizome (Zingiber officinale Rosc) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to gamma radiation. Radiat Res 160, no. 5 (2003): 584–92.
Khan, R., et al. Activity of solvent extracts of Prosopis spicigera, Zingiber officinale and Trachyspermum ammi against multidrug resistant bacterial and fungal. J Infect Dev Ctries 4, no. 5 (2010): 292–300.
Koh, E. M., et al. Modulation of macrophage functions by compounds isolated from Zingiber officinale. Planta Med 75, no. 2 (2009): 148–51.
Lakshmi, B. V., et al. Attenuation of acute and chronic restraint stress-induced perturbations in experimental animals by Zingiber officinale Roscoe. Food Chem Toxicol 48, no. 2 (2010): 530–35.
Lans, Cheryl. Ethnoveterinary medicines used to treat endoparasites and stomach problems in pigs and pets in British Columbia, Canada. Vet Parasitol 148, no. 3–4 (2007): 325–40.
Lee, S., et al. Liquid chromatographic determination of 6-, 8-, 10-gingerol and 6-shogaol in ginger (Zingiber officinale) as the raw herb and dried aqueous extract. J AOAC Int 90, no. 5 (2007): 1219–26.
Lin, R. J., et al. Larvicidal activities of ginger (Zingiber officinale) against Angiostrongylus cantonensis. Acta Trop 115, no. 1–2 (2010): 69–76.
Lin, R. J., et al. Larvicidal constituents of Zingiber officinale (ginger) against Anisakis simplex. Plant Med 76, no. 16 (2010): 1852–58.
Lopez, P., et al. Solid- and vapor-phase antimicrobial activities of six essential oils: susceptibility of selected foodborne bacterial and fungal strains. J Agric Food Chem 53, no. 17 (2005): 6939–46.
Maghsoudi, S., et al. Preventive effect of ginger (Zingiber officinale) pretreatment on renal ischemia-reperfusion in rats. Eur Surg Res 46, no. 1 (2011): 45–51.
Mahady, G. B., et al. Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Res 23, no. 5A (2003): 3699–702.
Malu, S. P., et al. Antibacterial activity and medicinal properties of ginger (Zingiber officinale). Global J Pure Applied Sci 15, no. 3 (2009): 365–68.
Masoud, H., et al. Comparing the effects of ginger (Zingiber officinale) extract and ibuprofen on patients with osteoarthritis. Arch Iran Med 8, no. 4 (2005): 267–71.
Merawin, L. T., et al. Screening of microfilaricidal effects of plant extracts against Dirofilaria immitis. Res Vet Sci 88, no. 1 (2010): 142–47.
Nagoshi, C., et al. Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE). Biol Pharm Bull 29, no. 3 (2006): 443–47.
Nanjundaiah, S. M., et al. Gastroprotective effect of ginger rhizome (Zingiber officinale) extract: role of gallic acid and cinnamic acid in H+, K+-ATPase/H. pylori inhibition and anti-oxidative mechanism. Evid Based Complement Alternat Med, no. 249487 (2011). E-pub (preprint) July 1, 2009. doi:10.1093/ecam/nep060.
Nogueira de Melo, G. A., et al. Inhibitory effects of ginger (Zingiber officinale Roscoe) essential oil on leukocyte migration in vivo and in vitro. J Nat Med 65, no. 1 (2011): 241–46.
Nya, E. J., et al. Use of dietary ginger, Zingiber officinale Roscoe, as an immunostimulant to control Aeromonas hydrophila infections in rainbow trout, Oncorhynchus mykiss (Walbaum). J Fish Dis 32, no. 11 (2009): 971–77.
Park, K. J. Evaluation of in vitro antiviral activity in methanol extracts against influenza virus type A from Korean medicinal plants. Phytother Res 17, no. 9 (2003): 1059–63.
Park, K. J., et al. In vitro antiviral activity of aqueous extracts from Korean medicinal plants against influenza virus type A. J Microbiol Biotechnol 15, no. 5 (2005): 924–29.
Park, M., et al. Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytother Res 22, no. 11 (2008): 1446–49.
Presser, Art. Ginger. Fact sheet in the Smart Supplementation series. Knoxville, Tenn.: Huntington College of Health Sciences, 2001. http://hchs.edu/literature/Ginger.pdf.
Raji, Y., et al. Anti-inflammatory and analgesic properties of the rhizome extract of Zingiber officinale. Afr J Biomed Res 5 (2002): 121–24.
Reinhard, G., et al. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8, no. 2 (2005): 125.
Sabul, B., et al. Caryophyllene-rich rhizome oil of Zingiber nimmonii from South India: chemical characterization and antimicrobial activity. Phytochemistry 67, no. 22 (2006): 2469–73.
Sasikumar, B., et al. Ginger. Extension pamphlet. Calicut, Kerala: Indian Institute of Spices Research, October 2008. http://spices.res.in/pdf/package/ginger.pdf.
Sephavand, R., et al. Ginger (Zingiber officinale Roscoe) elicits antinociceptive properties and potentiates morphine-induced analgesia in the rat radiant heat tail-flick test. J Med Food 13, no. 6 (2010): 1397–401.
Sharma, A., et al. Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J Pharm Sci 71, no. 2 (2009): 136–39.
Shivanand, D. J., et al. Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production. Phytochemistry 65 (2004): 1937–54.
Shukla, Y., et al. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol 45, no. 5 (2007): 683–90.
Singh, G., et al. Chemistry, antioxidant and antimicrobial investigations on essential oil and oleoresins of Zingiber officinale. Food Chem Toxicol 46, no. 10 (2008): 3295–302.
Sookkongwaree, K., et al. Inhibition of viral proteases by Zingiberaceae extracts and flavones isolated from Kaempferia parviflora. Pharmazie 61, no. 8 (2006): 717–21.
Srivastava, K. C., et al. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 39, no. 4 (1992): 342–48.
Stephens, James M. Ginger— Zingiber officinale Roscoe. Publication HS600 from the Horticultural Sciences Department, Florida Cooperative Extension Service, Institute of Food and Agricultural Sciences, University of Florida, May 1994 (reviewed March 2009). http://edis.ifas.ufl.edu/pdffiles/MV/MV06700.pdf.
Tan, B. K., et al. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review. Curr Med Chem 11, no. 11 (2004): 1423–30.
Thongson, C., et al. Antimicrobial effect of Thai spices against Listeria monocytogenes and Salmonella typhimurium CT104. J Food Prot 68, no. 10 (2005): 2054–58.
Ueda, H., et al. Repeated oral administration of a squeezed ginger (Zingiber officinale) extract augmented the serum corticosterone level and had anti-inflammatory properties. Biosci Biotechnol Biochem 74, no. 11 (2010): 2248–52.
van Breemen, R. B., et al. Cyclooxygenase-2 inhibitors in ginger (Zingiber officinale). Fitoterapia 82, no. 1 (2011): 38–43.
Wang, H. M., et al. Zingiber officinale (ginger) compounds have tetracycline-resistance modifying effects against clinical extensively drug-resistant Acinetobacter baumannii. Phytother Res 24, no. 12 (2010): 1825–30.
Wang, X., et al. Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res 20, no. 5 (2006): 335–41.
Wattanathorn, J., et al. Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat. Evid Based Complement Alternat Med, no. 429505 (2011). doi:10.1155/2011/429505.
Yip, Y. B., et al. An experimental study on the effectiveness of massage with aromatic ginger and orange essential oil for moderate-to-severe knee pain among the elderly in Hong Kong. Complement Ther Med 16, no. 3 (2008): 131–38.
Zhou, H. L., et al. The modulatory effects of the volatile oil of ginger on the cellular immune response in vitro and in vivo in mice. J Ethnopharmacol 105, no. 1–2 (2006): 301–5.
Zick, S. M., et al. Quantitation of 6-, 8- and 10-gingerols and 6-shogaol in human plasma by high-performance liquid chromatography with electrochemical detection. Int J Biomed 6, no. 3 (2010): 233–40.
Abdelatif, M., et al. Safety and efficacy of a new honey ointment on diabetic foot ulcers: a prospective pilot study. J Wound Care 17, no. 3 (2008): 108–10.
Acton, C. Medihoney: a complete wound bed preparation product. Br J Nurs 17, no. 11 (2008): S44, S46–48.
Adams, C. J., et al. Isolation by HPLC and characterization of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343, no. 4 (2008): 651–59.
Ahmed, A. K., et al. Honey-medicated dressing: transformation of an ancient remedy into modern therapy. Ann Plast Surg 50, no. 2 (2003): 143–47.
Alandejani, T., et al. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Head Neck Surg 141, no. 1 (2009): 114–18.
Alvarez-Suarez, J. M., et al. Antioxidant and antimicrobial capacity of several monofloral Cuban honeys and their correlation with color, polyphenol content and other chemical compounds. Food Chem Toxicol 48, no. 8–9 (2010): 2490–99.
Alese, O. B., et al. Pyoderma gangrenosum and ulcerative colitis in the tropics. Rev Soc Bras Med Trop 41, no. 6 (2008): 664–67.
Al-Jabri, A. A., et al. Antibacterial activity of Omani honey alone and in combination with gentamicin. Saudi Med J 26, no. 5 (2005): 767–71.
Al-Jabri, A. A., et al. In vitro antibacterial activity of Omani and African honey. Br J Biomed Sci 60, no. 1 (2003): 1–4.
Al-Waili, N. S. The antimicrobial potential of honey from United Arab Emirates on some microbial isolates. Med Sci Monit 11, no. 12 (2005): BR433–38.
———. Identification of nitric oxide metabolites in various honeys: effect of intravenous honey on plasma and urinary nitric oxide metabolites concentrations. J Med Food 6, no. 4 (2003): 359–64.
———. Investigating the antimicrobial activity of natural honey and its effects on the pathogenic bacterial infections of surgical wounds and conjunctiva. J Med Food 7, no. 2 (2004): 210–22.
———. Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and Candida albicans. Arch Med Res 36, no. 1 (2005): 10–13.
———. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res 6, no. 7 (2001): 306–8.
———. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions. Med Sci Monit 10, no. 8 (2004): MT94–98.
Armstrong, D. G. Manuka honey improved wound healing in patients with sloughy venous leg ulcers. Evid Based Med 14, no. 5 (2009): 148.
Asadi-Pooya, A. A., et al. The antimycobacterial effect of honey: an in vitro study. Riv Biol 96, no. 3 (2003): 491–95.
Attia, W. Y., et al. The anti-tumor effect of bee honey in Ehrlich ascite tumor model of mice is coincided with stimulation of the immune cells. Egypt J Immunol 15, no. 2 (2008): 169–83.
Aysan, E., et al. The role of intra-peritoneal honey administration in preventing post-operative peritoneal adhesions. Eur J Obstet Gynecol Reprod Biol 104, no. 2 (2002): 152–55.
Ayyildiz, A., et al. Intraurethral honey application for urethral injury: an experimental study. Int Urol Nephrol 39, no. 3 (2007): 815–21.
Badawy, O. F., et al. Antibacterial activity of bee honey and its therapeutic usefulness against Escherichia coli O157:H7 and Salmonella typhimurium infection. Rev Sci Tech 23, no. 3 (2004): 1011–22.
Baghel, P. S., et al. A comparative study to evaluate the effect of honey dressing and silver sulfadiazine dressing on wound healing in burn patients. Indian J Plast Surg 42, no. 2 (2009): 176–81.
Bang, L. M., et al. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med 9, no. 2 (2003): 267–73.
Bansal, V., et al. Honey—a remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J (KUMJ) 3, no. 3 (2005): 305–9.
Bardy, J., et al. A systematic review of honey uses and its potential value within oncology care. J Clin Nurs 17, no. 19 (2008): 2604–23.
Basson, N. J., et al. Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med 15, no. 8 (2008): 41.
Basualdo, C., et al. Comparison of the antibacterial activity of honey from different provenance against bacteria usually isolated from skin wounds. Vet Microbiol 124, no. 3–4 (2007): 375–81.
Bell, S. G. The therapeutic use of honey. Neonatal Netw 26, no. 4 (2007): 247–51.
Beretta, G., et al. Quinoline alkaloids in honey: further analytical (HPLC-DAD-ESI-MS, multidimensional diffusion-ordered NMR spectroscopy), theoretical and chemometric studies. J J Pharm Biomed Anal 50, no. 3 (2009): 432–39.
Betts, J. The clinical application of honey in wound care. Nurs Times 104, no. 14 (2008): 43–44.
Bittman, S., et al. Does honey have a role in paediatric wound management? Br J Nurs 19, no. 15 (2010): S19–24 passim.
Blair, S. E., et al. The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Microbiol Infect Dis 28, no. 10 (2009): 1199–208.
Blaser, G., et al. Effect of medical honey on wounds colonized or infected with MRSA. J Wound Care 16, no. 8 (2007): 325–28.
Boorn, K. L., et al. Antimicrobial activity of honey from the stingless bee Trigona carbonaria determined by agar diffusion, agar dilution, broth microdilution and time-kill methodology. J Appl Microbial 108, no. 5 (2010): 1534–43.
Boukraâ, L., et al. Additive action of honey and starch against Candida albicans and Aspergillus niger. Rev Iberoam Micol 24, no. 4 (2007): 309–11.
Boukraâ, L., et al. Additive activity of royal jelly and honey against Pseudomonas aeruginosa. Altern Med Rev 13, no. 4 (2008): 330–33.
Boukraâ, L., et al. Honey use in burn management: potentials and limitations. Forsch Komplementmed 17, no. 2 (2010): 74–80.
Boukraâ, L., et al. Rediscovering the antibiotics of the hive. Recent Pat Antiinfect Drug Discov 4, no. 3 (2009): 206–13.
Boukraâ, L., et al. Sahara honey shows higher potency against Pseudomonas aeruginosa compared to north Algerian types of honey. J Med Food 10, no. 4 (2007): 712–14.
Boukraâ, L., et al. Synergistic action of starch and honey against Aspergillus niger in correlation with diastase number. Mycoses 51, no. 6 (2008): 520–22.
Boukraâ, L., et al. Synergistic action of starch and honey against Pseudomonas aeruginosa in correlation with diastase number. J Altern Complement Med 14, no. 2 (2008): 181–84.
Chambers, J. Topical manuka honey for MRSA-contaminated skin ulcers. Palliat Med 20, no. 5 (2006): 557.
Chang, J., et al. The use of honey for wound care management: a traditional remedy revisited. Home Healthc Nurse 27, no. 5 (2009): 308–16.
Chernev, I., et al. Combined noncontact, low-frequency ultrasound and medical honey for the treatment of chronic wounds: a case series. J Wound Ostomy Continence Nurs 37, no. 4 (2010): 421–25. E-pub (preprint) 2010.
Cooper, R. Honey in wound care: antibacterial properties. GMS Krankenhhyg Interdiszip 2, no. 2 (2007): doc. 51.
Cooper, R. Using honey to inhibit wound pathogens. Nurs Times 104, no. 3 (2008): 46, 48–49.
Cooper, R. A., et al. Absence of bacterial resistance to medical-grade manuka honey. Eur J Microbiol Infect Dis 29, no. 10 (2010): 1237–41.
Cooper, R. A., et al. Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J Royal Soc Med 92 (1999): 283–85.
Cooper, R. A., et al. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil 23, no. 6 (2002): 366–70.
Cooper, R. A., et al. Honey, health and longevity, Curr Aging Sci 3, no. 3 (2010): 239–41. E-pub (preprint) 2010.
Cooper, R. A., et al. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93, no. 5 (2002): 857–63.
Cutting, K. F. Honey and contemporary wound care: an overview. Ostomy Wound Manage 53, no. 11 (2007): 49–54.
Dai, T., et al. Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov 5, no. 2 (2010): 124–51.
Dunford, C. The use of honey-derived dressings to promote effective wound management. Prof Nurse 20, no. 8 (2005): 35–38.
Dunwoody, G., et al. The use of medical grade honey in clinical practice. Br J Nurs 17, no. 20 (2008): S38–44.
Eddy, J. J., et al. Practical consideration of using topical honey for neuropathic diabetic foot ulcers: a review. WMJ 107, no. 4 (2008): 187–90.
Emsen, M. A different and safe method of split thickness skin graft fixation: medical honey application. Burns 33, no. 6 (2007): 782–87.
English, H. K., et al. The effect of manuka honey on plaque and gingivitis: a pilot study. J Int Acad Periodontol 6, no. 2 (2004): 63–67.
Ergul, E., et al. The effect of honey on the intestinal anastomotic wound healing in rats with obstructive jaundice. Bratisl Lek Listy 111, no. 5 (2010): 265–70.
Estevinho, L., et al. Antioxidant and antimicrobial effects of phenolic compounds extracts of northeast Portugal honey. Food Chem Toxicol 46, no. 12 (2008): 3774–79.
Estrada, H., et al. Evaluation of the antimicrobial action of honey against Staphyloccocus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Salmonella enteritidis, Listeria monocytogenes and Aspergillus niger. Evaluation of its microbiological charge. Arch Latinoam Nutr 55, no. 2 (2005): 167–71.
Eyarefe, O. D., et al. Small bowel responses to enteral honey and glutamine administration following massive small bowel resection in rabbit. Afr J Med Sci 37, no. 4 (2008): 309–14.
Fangio, M. F., et al. Antimicrobial activity of honey the southeast of Buenos Aires Province against Escherichia coli. Rev Argent Microbiol 39, no. 2 (2007): 120–23.
French, V. M., et al. The antibacterial activity of honey against coagulase-negative staphylococci. J Antimicrob Chemother 56, no. 1 (2005): 228–31.
Genacias-Acuna, E. F. Active Leptospermum honey and negative pressure wound therapy for nonhealing postsurgical wounds. Ostomy Wound Manage 56, no. 3 (2010): 10–12.
Gethin, G., et al. Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: an RCT. J Wound Care 17, no. 6 (2008): 241–44, 246–47.
Gethin, G., et al. Case series of use of manuka honey in leg ulceration. Int Wound J 2, no. 1 (2005): 10–15.
Gethin, G., et al. Manuka honey vs. hydrogel–a prospective, open label, multicentre, randomized controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs 18, no. 3 (2009): 466–74.
Gethin, G. T., et al. The impact of manuka honey dressings on the surface pH of chronic wounds. Int Wound J 5, no. 2 (2008): 185–94.
Gollu, A., et al. Effect of honey on intestinal morphology, intraabdominal adhesions and anastomotic healing. Phytother Res 22, no. 9 (2008): 1243–47.
Gottrup, F., et al. Current management of wound healing. G Ital Dermatol Venereol 144, no. 3 (2009): 217–28.
Gupta, A. K., et al. Role of antifungal agents in the treatment of seborrheic dermatitis. Am J Clin Dermatol 5, no. 6 (2004): 417–22.
Gurdal, M., et al. Predisposing factors and treatment outcome in Fournier’s gangrene. Analysis of 28 cases. Urol Int 70, no. 4 (2003): 286–90.
Hashemi B., et al. Comparison between topical honey and mafenide acetate in treatment of auricular burn. Am J Otolaryngol 32, no. 1 (2011): 28–31. E-pub (preprint) November 24, 2009.
Hendrickson, M. A. Utilizing active Leptospermum honey dressings in the treatment of cutaneous small-vessel vasculitis. Ostomy Wound Manage 56, no. 4 (2010): 10–12.
Henriques A., et al. Free radical production and quenching in honeys with wound healing potential. J Antimicrob Chemother 58, no. 4 (2006): 773–77.
Henriques A. F., et al. The intracellular effects of manuka honey on Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 29, no. 1 (2010): 45–50.
Heppermann, B. Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary. Bet 3. Honey for the symptomatic relief of cough in children with upper respiratory tract infections. Emerg Med J 26, no. 7 (2009): 522–23.
Holzgreve, H. Honey is better than aciclovir in herpes. MMW Fortschr Med 147, no. 3 (2005): 18.
Hon, J. Using honey to heal a chronic wound in a patient with epidermolysis bullosa. Br J Nurs 14, no. 19 (2005): S4–10 passim.
Iftikhar F., et al. Effects of acacia honey on wound healing in various rat models. Phytother Res 24, no. 4 (2010): 583–86.
Ingle, R., et al. Wound healing with honey—a randomised controlled trial. S Afr Med J 96, no. 9 (2006): 831–35.
Irish, J., et al. Antibacterial activity of honey from the Autralian stingless bee Trigona carbonaria. Int J Antimicrob Agents 32, no. 1 (2008): 89–90.
Irish, J., et al. Honey has an antifungal effect against Candida species. Med Mycol 44, no. 3 (2006): 289–91.
Johnson, D. W., et al. The honeypot study of protocol: a randomized controlled trial of exit-site application of Medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit Dial Int 29, no. 3 (2009): 303–9.
Jull, A., et al. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 95, no. 2 (2008): 175–82.
Jull, A. B, et al. Honey as a topical treatment of wounds. Cochrane Database Syst Rev 8, no. 4 (2008): CD005083.
Khan, F. R., et al. Honey: nutritional and medicinal value. Int J Clin Pract 61, no. 10 (2007): 1705–7.
Khanal, B., et al. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg 39, no. 12 (2010): 1181–85. E-pub (preprint) September 15, 2010.
Khoo, Y. T., et al. Wound contraction effects and antibacterial properties of tualang honey on full-thickness burn wounds in rats in comparison to hydrofibre. BMC Complement Altern Med 10 (2010): 48.
Kiefer, S., et al. (E,Z)-3-(3′,5′-dimethoxy-4′-hydroxy-benzylidene)-2-indolinone blocks mast cell degranulation. Eur J Pharm Sci 40, no. 2 (2010): 143–47.
Koc, A. N., et al. Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp: an in vitro evaluation. Med Mycol 47, no. 7 (2009): 707–12.
Kwakman, P. H., et al. How honey kills bacteria. FASEB J 24, no. 7 (2010): 2576–82.
Kwakman, P. H., et al. Medical-grade honey enriched with antimicrobial peptides has enhanced activity against antibiotic-resistant pathogens. Eur J Clin Microbiol Infect Dis 30, no. 2 (2011): 251–57. E-pub (preprint) October 7, 2010.
Kwakman, P. H., et al. Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 46, no. 11 (2008): 1677–82.
Langemo, D. K., et al. Use of honey for wound healing. Adv Skin Wound Care 22, no. 3 (2009): 113–18.
Lay-flurrie, K. Honey in wound care: effects, clinical application and patient benefit. Br J Nurs 17, no. 11 (2008): S30, S32–36.
Lotfy, M., et al. Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. Br J Biomed 63, no. 4 (2006): 171–73.
Lusby, P. E., et al. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 36, no. 5 (2005): 464–67.
Lusby, P. E., et al. A comparison of wound healing following treatment with Lavandula × allardii honey or essential oil. Phytother Res 20, no. 9 (2006): 755–57.
Maeda, Y., et al. Antibacterial activity of honey against community-associated methicillin-resistant Staphyloccocus aureus (CA-MRSA). Complement Ther Clin Pract 14, no. 2 (2008): 77–82.
Majtán, J. Apitherapy—the role of honey in the chronic wound healing process. Epidemiol Mikrobiol Imunol 58, no. 3 (2009): 137–40.
Majtan, J., et al. Effect of honey and its major royal jelly protein 1 on cytokine and MMP-9 mRNA transcripts in human keratinocytes. Exp Dermatol 19, no. 8 (2010): e73–79.
Majtan, J., et al. Honeydew honey as a potent antibacterial agent in eradiation of multi-drug resistant Stenotrophomonas maltophilia isolates from cancer patients. Phytother Res 25, no. 4 (2011): 584–87. E-pub (preprint) September 29, 2010.
Majtan, J., et al. Is manuka honey the best type of honey for wound care? J Hosp Infect 74, no. 3 (2010): 305–6.
Makhdoom, A., et al. Management of diabetic foot by natural honey. J Ayub Med Coll Abbottabad 21, no. 1 (2009): 103–5.
Martos, I., et al. Flavonoids in monospecific eucalyptus honeys from Australia. J Agric Food Chem 48, no. 10 (2000): 4744–48.
Mavric, E., et al. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52, no. 4 (2008): 483–89.
McIntosh, C. D., et al. Honey dressing versus paraffin tulle gras following toenail surgery. J Wound Care 15, no. 3 (2006): 133–36.
Mercan, N., et al. Antimicrobial activity and pollen composition of honey samples collected from different provinces in Turkey. Nat Prod Res 21, no. 3 (2007): 187–95.
Merckoll, P., et al. Bacteria, biofilm and honey: a study of the effects of honey on “planktonic” and biofilm-embedded chronic wound bacteria. Scand J Infect Dis 41, no. 5 (2009): 341–47.
Miorin, P. L., et al. Antibacterial activity of honey and propolis from Apis mellifera and Tetragonisca angustula against Staphylococcus aureus. J Appl Microbiol 95, no. 5 (2003): 913–20.
Misirlioglu, A., et al. Use of honey as an adjunct in the healing of split-thickness skin graft donor site. Dermatol Surg 29, no. 2 (2003): 168–72.
Moghazy, A. M., et al. The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract 89, no. 3 (2010): 276–81.
Molan, P. C. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds 5, no. 1 (2006): 40–54.
Molan, P. C., et al. Using honey to heal diabetic foot ulcers. Adv Skin Wound Care 21, no. 7 (2008): 313–16.
Moolanaar, M., et al. The effect of honey compared to conventional treatment on healing of radiotherapy-induced skin toxicity in breast cancer patients. Acta Oncol 45, no. 5 (2006): 623–24.
Motallebnejad, M., et al. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. J Contemp Dent Pract 9, no. 3 (2008): 40–47.
Mphande A. N., et al. Effects of honey and sugar dressings on wound healing. J Wound Care 16, no. 7 (2007): 317–19.
Mullai, V., et al. Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa. J Altern Complement Med 13, no. 4 (2007): 439–41.
Mundo, M. A., et al. Growth inhibition of foodborne pathogens and food spoilage organisms by select raw honeys. Int J Food Microbiol 97, no. 1 (2004): 1–8.
Namias, N. Honey in the management of infections. Surg Infect (Larchmont) 4, no. 2 (2003): 219–26.
Nasir, N. A., et al. Antibacterial properties of tualang honey and its effect in burn wound management: a comparative study. BMC Complement Altern Med 10 (2010): 31.
Natarajan, S., et al. Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 12, no. 1 (2001): 33–36.
Ndayisaba, G., et al. Treatment of wounds with honey. 40 cases. Presse Med 21, no. 32 (1992): 1516–18.
Oduwole, O., et al. Honey for acute cough in children. Cochrane Database Syst Rev 20, no. 1 (2010): CD007094.
Okeniyi, J. A., et al. Comparison of healing of incised abcess wounds with honey and EUSOL dressing. J Altern Complement Med 11, no. 3 (2005): 511–13.
Oladejo, O. W., et al. A comparative study of the wound healing properties of honey and Ageratum conyzoides. Afr J Med Sci 32, no. 2 (2003): 193–96.
Olaitan, P. B., et al. Honey: a reservoir for microorganisms and an inhibitory agent for microbes. Afr Health Sci 7, no. 3 (2007): 159–65.
Osuagwu, F. C., et al. Enhanced wound contraction in fresh wounds dressed with honey in Wistar rats (Rattus novergicus). West Afr J Med 23, no. 2 (2004): 114–18.
Ousey, K., et al. Topical antimicrobial agents for the treatment of chronic wounds. Br J Community Nurs 14, no. 9 (2009): S6–10 passim.
Panknin, H. T. Wound management with medicinal honey: an effective alternative to antiseptics especially in young children. Kinderkrankenschwester 28, no. 1 (2009): 29–30.
Patton, T., et al. Use of a spectrophotometric bioassay for determination of microbial sensitivity to manuka honey. J Microbiol Methods 64, no. 1 (2006): 84–95.
Paul, I. M., et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 161, no. 12 (2007): 1140–46.
Pieper, B. Honey-based dressings and wound care: an option for care in the United States. J Wound Ostomy Continence Nurs 36, no. 1 (2009): 60–66; quiz 67–68.
Rashad, U. M., et al. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol 123, no. 2 (2009): 223–28.
Robson, V., et al. Standardized antibacterial honey (Medihoney) with standard therapy in wound care: randomized clinical trial. J Adv Nurs 65, no. 3 (2009): 565–75.
Robson, V., et al. Using leptospermum honey to manage wounds impaired by radiotherapy: a case series. Ostomy Wound Manage 55, no. 1 (2009): 38–47.
Rossiter, K., et al. Honey promotes angiogeneic activity in the rat aortic ring assay. J Wound Care 19, no. 10 (2010): 440, 442–46.
Rudzka-Nowak, A., et al. Application of manuka honey and GENADYNE A4 negative pressure wound therapy system in a 55-year old woman with extensive phlegmonous and necrotic lesions in the abdominal integuments and lumbar region after traumatic rupture of the colon. Med Sci Monit 16, no. 11 (2010): CS138–42.
Saber, A. Effect of honey versus intergel in intraperitoneal adhesion prevention and colonic anastomotic healing: a randomized controlled study in rats. Int J Surg 8, no. 2 (2010): 121–27.
Salomon, D., et al. Honey: from Noe to wound care. Rev Med Suisse 6, no. 246 (2010): 871–74.
Sare, J. L. Leg ulcer management with topical medical honey. Br J Community Nurs 13, no. 9 (2008): S22–26 passim.
Sayad, S. M., et al. Immune defense of rats immunized with fennel honey, propolis, and bee venom against staphylococcal infection. J Med Food 12, no. 3 (2009): 569–75.
Schumacher, H. H. Use of medical honey in patients with chronic venous leg ulcers after split-skin grafting. J Wound Care 13, no. 10 (2004): 451–52.
Shadkam, M. N., et al. A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents. J Altern Complement Med 16, no. 7 (2010): 787–93.
Sharp, A. Beneficial effects of honey dressings in wound management. Nurs Stand 24, no. 7 (2009): 66–72 passim.
Shukrimi, A., et al. A comparative study between honey and povidone iodine as dressing solution for Wagner type II diabetic foot ulcers. Med J Malaysia 63, no. 1 (2008): 44–46.
Simon, A., et al. Antibacterial honey (Medihoney) for wound care of immunocompromised pediatric oncology patients. GMS Krankenhhyg Interdiszip 1, no. 1 (2006): doc. 18.
Simon, A., et al. Wound care with antibacterial honey (Medihoney) in pediatric hematologyoncology. Support Care Cancer 14, no. 1 (2006): 91–97.
Staunton, C. J., et al. The use of honey as a topical dressing to treat a large, devitalized wound in a stumptail macaque (Macaca arctoides). Contemp Top Lab Anim Sci 44, no. 4 (2005): 43–45.
Stephen-Haynes, J. Evaluation of a honey-impregnated tulle dressing in primary care. Br J Community Nurs Suppl (2004): S21–27.
Tan, H. T., et al. The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey. BMC Complement Altern Med 15, no. 9 (2009): 34.
Tanih, N. F., et al. An African perspective on Helicobacter pylori: prevalence of human infection, drug resistance, and alternative approaches to treatment. Ann Trop Med Parasitol 103, no. 3 (2009): 189–204.
Temaru, E., et al. Antibacterial activity of honey from stingless honeybees (Hymenoptera; Apidae; Meliponinae). Pol J Microbiol 56, no. 4 (2007): 281–85.
Timm, M., et al. Immunomodulatory effects of honey cannot be distinguished from endotoxin. Cytokine 42, no. 1 (2008): 113–20.
Tonks, A. J., et al. A 5.8-kDa component of manuka honey stimulates immune cells via TLR4. J Leukoc Biol 82, no. 5 (2007): 1147–55.
Tonks, A. J., et al. Honey stimulates inflammatory cytokine production from monocytes. Cytokine 21, no. 5 (2003): 242–47.
Tshukudu, G. M., et al. Comparative in vitro study of honey based and silver based wound preparations on cell viability. Burns 36, no. 7 (2010): 1036–41.
Tushar, T., et al. Effect of honey on CYP3A4, CYP2D6 and CYP2C19 enzyme activity in healthy human volunteers. Basic Clin Pharmacol Toxicol 100, no. 4 (2007): 269–72.
van den Berg, A. J., et al. An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey. J Wound Care 17, no. 4 (2008): 172–74, 176–78.
Van der Weyden, E. A. Treatment of a venous leg ulcer with a honey alginate dressing. Br J Community Nurs, June 2005, suppl.: S21–27 passim.
———. The use of honey for the treatment of two patients with pressure ulcers. Br J Community Nurs 8, no. 12 (2003): S14–20.
Visavadia, B. G., et al. Manuka honey dressing: an effective treatment for chronic wound infections. Br J Oral Maxillofac Surg 46, no. 1 (2008): 55–56.
Visavadia, B. G., et al. Manuka honey dressing: an effective treatment for chronic wound infections. Br J Oral Maxillofac Surg 46, no. 8 (2008): 696–97.
Wang, X. H., et al. Antimutagenic effect of various honeys and sugars against Trp-p-1. J Agric Food Chem 50, no. 23 (2002): 6923–28.
White, R. The benefits of honey in wound management. Nurs Stand 20, no. 10 (2005): 57–64: quiz 66.
Wijesinghe, M., et al. Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J 122, no. 1295 (2009): 47–60.
Wilkinson, J. M., et al. Antibacterial activity of 13 honeys against Escherichia coli and Pseudomonas aeruginosa. J Med Food 8, no. 1 (2005): 100–103.
Wilson, V. Assessment and management of fungating wounds: a review. Br J Community Nurs 10, no. 3 (205): S28–34.
Yapucu, G., et al. Effectiveness of a honey dressing for healing pressure ulcers. J Wound Ostomy Continence Nurs 34, no. 2 (2007): 184–90.
Yuzbasioglu, M. F., et al. Administration of honey to prevent peritoneal adhesions in a rat peritonitis model. Int J Surg 7, no. 1 (2009): 54–57.
Zeiger, B. The use of active Leptospermum honey dressings to re-initiate the wound healing process. Ostomy Wound Manage 56, no. 1 (2010): 10.
Zeina, B., et al. Effect of honey versus thyme on rubella virus survival in vitro. J Altern Complement Med 2, no. 3 (1996): 345–48.
Zhao, Y. L., et al. Effects of different extracts from radix isatidis lymphocytes of mice by biothermodynamics. Zhongguo Zhong Yao Za Zhi 31, no. 7 (2006): 590–93.
Akkol, E. K., et al. A comparative study on the antinociceptive and anti-inflammatory activities of five Juniperus taxa. J Ethnopharamacol 125, no. 2 (2009): 330–36.
Ali, S. A., et al. Protective role of Juniperus phoenicea and Cupressus sempervirens against CCI4. World J Gastrointest Pharmacol Ther 1, no. 6 (2010): 123–31.
Almaarri, K., et al. Volatile compounds from leaf extracts of Juniperus excels a growing in Syria via gas chromatography mass spectrometry±. Anal Methods 2 (2010): 673–77.
Al-Mustafa, A. H., et al. Antioxidant activity of some Jordanian medicinal plants used traditionally for the treatment of diabetes. Pak J Biol Sci 11, no. 3 (2008): 351–58.
Al-Qahtani, S. J., and M. Al-Shawaf. In vitro study effectiveness of Saudi plants’ extracts against selected microorganisms. Abstract of a poster presentation at the preliminary program for the Saudi Dental Society Annual Scientific Meeting and IADR–Saudi Arabian Section General Assembly Meeting, Riyadh, Saudi Arabia, January 10–13, 2005. http://iadr.confex.com/iadr/saudi05/preliminaryprogram/abstract_71741.htm.
Angioni, A., et al. Chemical composition of the essential oils of Juniperus from ripe and unripe berries and leaves and their antimicrobial activity. J Agric Food Chem 51, no. 10 (2003): 3073–78.
Anonymous. Chinese medicine treatment of chronic obstructive pulmonary disease research. Free Papers Download Center, August 4, 2009. http://eng.hi138.com/?i120068.
Anonymous. Chinese medicine treatment of depression status. Free Papers Download Center, June 19, 2008. http://eng.hi138.com/?i123796.
Anonymous. Juniper berry. Brief monograph in the herb encyclopedia maintained by Flora Manufacturing and Distributing. http://florahealth.com/herbal_encyclopedia_int.cfm (accessed March 22, 2011).
Anonymous. Totarol. http://en.wikipedia.org/wiki/Totarol (accessed November 25, 2010).
Ateş, D. A., et al. Antimicrobial activities of various medicinal and commercial plant extracts. Turk J Biol 27 (2003): 157–62.
Barjaktaroviċ, B., et al. Chemical composition of Juniperus communis L. fruits supercritical CO2 extracts: dependence on pressure and extraction time. J Agric Food Chem 53, no. 7 (2005): 2630–36.
Bergner, P. Juniperus: are juniper berries a kidney irritant? Medical Herbalism 6, no. 2 (1994): 12.
Butani, L., et al. Amelioration of tacrolimus-induced nephrotoxicity in rats using juniper oil. Transplantation 76, no. 2 (2003): 306–11.
Caldecott, T. Juniperus communis, Pinaceae. http://toddcaldecott.com/index.php/herbs/learning-herbs (accessed November 22, 2010).
Chavali, S. R., et al. Increased production of TNF-alpha and decreased levels of dienoic eicosanoids, IL-6 and IL-10 in mice fed menhaden oil and juniper oil diets in response to an intraperitoneal lethal dose of LPS. Prostaglandins Leukot Essent Fatty Acids 59, no. 2 (1998): 89–93.
Clark, A. M., et al. Antimicrobial properties of heartwood, bark/sapwood and leaves of Juniperus species. Phytother Res 4, no. 1 (1990): 15–19.
Committee on Herbal Medicinal Products (HMPC). List of references supporting the assessment of Juniperus communis L., pseudo-fructus. European Medicines Agency, November 12, 2009. http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_List_of_references_ supporting_the_assessment_report/2011/02/WC500102145.pdf.
Derwich, E., et al. Chemical composition of leaf essential oil of Juniperus phoenicea and evaluation of its antibacterial activity. Int J Agric Biol 12 (2010): 199–204.
Diğrak, M., et al. Antimicrobial activities of several parts of Pinus brutia, Juniperus oxycedrus, Abies ciclicia, Cedrus libani and Pinus nigra. Phytother Res 13, no. 7 (1999): 584–87.
El Sawi, S. A., and H. M. Motawe. Labdane, pimarane and abietane diterpenes from the fruits of Juniperus phoenicea L. grown in Egypt and their activities against human liver carcinoma. Can J Pure Appl Sci 2, no. 1 (2008): 115–22.
El Sawi, S. A., et al. Chemical composition, cytotoxic activity and antimicrobial activity of essential oils of leaves and berries of Juniperus phoenicea L. grown in Egypt. Afr J Tradit Complement Altern Med 4, no. 4 (2007): 417–26.
Ennajar, M., et al. The influence of organ, season and drying method on chemical composition and antioxidant and antimicrobial activities of Juniperus phoenicea L. essential oils. J Sci Food Agric 90, no. 3 (2010): 462–70.
Filipowicz, N., et al. Antibacterial and antifungal activity of juniper berry oil and its selected components. Phytotherapy Research 17 (2003): 227–31.
Filipowicz, N., et al. The phytochemical and genetic survey of common and dwarf juniper (Juniperus communis and Juniperus nana) identifies chemical races and close taxonomic identity of species. Planta Med 72, no. 9 (2006): 850–53.
Gavini, E., et al. Solid lipid microparticles (SLM) containing juniper oil anti-acne topical carriers: preliminary studies. Pharm Dev Technol 10, no. 4 (2005): 479–87.
Ghrabi, Zeineb. Juniperus phoenicia L. In A Guide to Medicinal Plants in North Africa, 161–63. Malaga, Spain: IUCN Center for Mediterranean Cooperation, 2005.
Gordien, A. Y., et al. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). J Ethnopharmacol 126, no. 3 (2009): 500–505.
Jaiswal, R., et al. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. Biochemistry 46, no. 14 (2007): 4211–20.
Jimenez-Arellanes, A., et al. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases. Phytother Res 17, no. 8 (2003): 903–8.
Johnston, W. H., et al. Antimicrobial activity of some Pacific Northwest woods against anaerobic bacteria and yeast. Phytother Res 15, no. 7 (2001): 586–88.
Jones, S. M., et al. Dietary juniper berry oil minimizes hepatic reperfusion injury in the rat. Hepatology 28, no. 4 (1998): 1042–50.
Karaman, F., et al. Antimicrobial activity of aqueous and methanol extracts of Juniperus oxycedrus L. J Ethnopharmacol 85, no. 2–3 (2003): 231–35.
Karchesy, J. The literature of juniper utilization for oils and specialty products: a report to the Western Juniper Steering Committee. Corvallis: Oregon State University Department of Forest Products, April 1, 1998. http://juniper.oregonstate.edu/bibliography/documents/php80YmFy_literature.pdf.
Kozan, E., et al. Evaluation of some plants used in Turkish folk medicine against parasitic infections for their in vivo anthelmintic activity. J Ethnopharmacol 108, no. 2 (2006): 211–16.
Lamnauer, D. Juniperus oxycedrus L. In A Guide to Medicinal Plants in North Africa, 157–160. Malaga, Spain: IUCN Center for Mediterranean Cooperation, 2005.
Lesjak, M. M., et al. Juniperus sibirica Burgsdorf as a novel source of antioxidant and anti-inflammatory agents. Food Chemistry 124, no. 3 (2010): 850–56.
Loizzo, M. R., et al. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers 5, no. 3 (2008): 461–70.
Mahady, G. B., et al. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Pytother Res 19, no. 11 (2005): 988–91.
Marino, A., et al. In vitro effect of branch extracts of Juniperus species from Turkey on Staphylococcus aureus biofilm. FEMS Immunol Med Microbiol 59, no. 3 (2010): 470–76.
Martz, F., et al. Effect of latitude and altitude on the terpenoid and soluble phenolic composition of juniper (Juniperus communis) needles and evaluation of their antibacterial activity in the boreal zone. J Agric Food Chem 57, no. 20 (2009): 9575–84.
Miceli, N., et al. Comparative analysis of flavonoid profile, antioxidant and antimicrobial activity of the berries of Juniperus communis L. var. communis and Juniperus communis L. var. saxatilis Pall. from Turkey. J Agric Food Chem 57, no. 15 (2009): 6570–77.
Moein, M. R., et al. Analysis of antimicrobial, antifungal and antioxidant activities of Juniperus excelsa M. B subsp. polycarpos (K. Koch) Takhtajan essential oil. Pharmacognosy Res 2, no. 3 (2010): 128–31.
Mossa, J. S., et al. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazine. Phytother Res 18 (2004): 934–37.
Nixon, D., and D. Hobbs. The use of totarol to treat acne in an adolescent: a case study. NZFP (New Zealand Family Physician) 33, no. 4 (2006): 1–3, 2006.
Orhan, N., et al. Effects of Juniperus oxycedrus ssp. oxycedrus on tissue lipid peroxidation, trace elements (Cu, Zn, Fe) and blood glucose levels in experimental diabetes. J Ethnopharmacol 133, no. 2 (2011): 759–64.
Ottavioli, J., et al. Chemical variability of the needle oil of Juniperus communis ssp. alpina from Corsica. Chem Biodivers 6, no. 12 (2009): 2192–99.
Pankaj, K., et al. Identification of phytochemical content and antibacterial activity of Juniperus communis leaves. Int J Biotechnol Biochem 6, no. 1 (2004): 87–91.
Pepeljnjak, S., et al. Antimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae). Acta Pharm 55, no. 4 (2005): 417–22.
Pubget. [Juniperus articles and abstracts.] http://pubget.com (search for “juniperus”; accessed November 22, 2010).
Rezvani, S., et al. Analysis and antimicrobial activity of the plant Juniperus communis. Rasāyan J Chem 2, no. 2 (2009): 257–60.
Sadeghi-aliabadi, H., et al. Evaluation of in vitro cytotoxic effects of Juniperus foetidissima and Juniperus sabina extracts against a panel of cancer cells. Iran J Pharm Res 8, no. 4 (2009): 281–86.
Salido, S., et al. Chemical studies of essential oils of Juniperus oxycedrus ssp. badia. J Ethnopharmacol 81, no. 1 (2002): 129–34.
Samoylenko, V., et al. Antiparasitic, nematicidal and antifouling constituents from Juniperus berries. Phytother Res 22, no. 12 (2008): 1570–76.
San Feliciano, A., et al. Antineoplastic and antiviral activities of some cyclolignans. Planta Med 59, no. 3 (1993): 246–49.
Sati, S. C., et al. Antibacterial potential of leaf extracts of Juniperus communis L. from Kumaun Himalaya. Afr J Microbiol Res 4, no. 12 (2010): 1291–94.
Schneider, I., et al. Inhibitory activity of Juniperus communis on 12(S)-HETE production in human platelets. Planta Med 70, no. 5 (2004): 471–74.
Smith, E. C., et al. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother 51, no. 12 (2007): 4480–83.
Van Slambrouck, S., et al. Effects of crude aqueous medicinal plant extracts on growth and invasion of breast cancer cells. Oncol Rep 17, no. 6 (2007): 1487–92.
Wanner, J., et al. Chemical composition and antibacterial activity of selected essential oils and some of their main compounds. Nat Prod Commun 5, no. 9 (2010): 1359–64.
Webster, D., et al. Antimycobacterial screening of traditional medicinal plants using the microplate resazurin assay. Can J Microbiol 56, no. 6 (2010): 487–94.
Acharya, S. K., et al. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Indian J Med Res 98 (1993): 69–74.
Adams, L. S., et al. Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med 3, no. 1 (2006): 117–24.
Agarwal, A., et al. An evolution of the efficacy of licorice gargle for attenuating postoperative sore throat: a prospective, randomized, single-blind study. Anesth Analg 109, no. 1 (2009): 77–81.
Aiyegoro, O. A., et al. Use of bioactive plant products in combination with standard antibiotics: implications in antimicrobial chemotherapy. J Med Plants Res 3, no. 13 (2009): 1147–52.
Aly, A. M. Licorice: a possible anti-inflammatory and anti-ulcer drug. AAPS PharmSciTech 6, no. 1 (2005): E74–82.
Ambawade, S. D., et al. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Ind J Pharmacol 34 (2002): 251–55.
Anonymous. Glycyrrhiza. Wikipedia. http://en.wikipedia.org/wiki/Glycyrrhiza (accessed February 7, 2011).
Anonymous. Glycyrrhiza glabra. Altern Med Rev 10, no. 3 (2005): 230–37.
Anonymous. Glycyrrhiza L. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=GLYCY (accessed February 7, 2011).
Anonymous. Glycyrrhiza lepidota. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=GLLE3 (accessed December 20, 2011).
Anonymous. Glycyrrhiza uralensis. Wikipedia. http://en.wikipedia.org/wiki/Glycyrrhiza_uralensis (accessed February 7, 2011).
Anonymous. Liquorice. Wikipedia. http://en.wikipedia.org/wiki/Liquorice (accessed February 7, 2011).
Aoki, F., et al. Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans. J Am Coll Nutr 26, no. 3 (2007): 209–18.
Armanini, D., et al. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 131, no. 1 (2007): 61–67.
Asl, M. N., et al. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22, no. 6 (2008): 709–24.
Badam, L. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Dis 29, no. 2 (1997): 91–99.
Barthomeuf, C., et al. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Planta Med 72, no. 7 (2006): 634–39.
Belofsky, G., et al. Metabolites of the “smoke tree,” Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. J Nat Prod 69, no. 2 (2006): 261–64.
Belofsky, G., et al. Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod 67, no. 3 (2004): 481–84.
Betoni, J. E. C., et al. Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem Inst Oswaldo Cruz 101, no. 4 (2006): 387–90.
Biavatti, Maique W. Synergy: an old wisdom, a new paradigm for pharmacotherapy. Braz J Pharm Sci 45, no. 3 (2009): 371–78.
Biradar, Y. Evaluation of antimalarial activity of selected plants of Indian systems of medicine and study: the synergistic activity of the compounds present therein. PhD diss., Nirma University (India), December 9, 2010. http://ietd.inflibnet.ac.in/handle/10603/1379.
Bojian, B., et al. Glycyrrhiza Linnaeus. In Flora of China 10, 509–11. St. Louis, MS: Missouri Botanical Garden Press; Beijing: Science Press, 2010.
Burgess, J. A. Review of over-the-counter treatments for aphthous ulceration and results from use of a dissolving oral patch containing glycyrrhiza complex herbal extract. J Contemp Dent Pract 9, no. 3 (2008): 88–98.
Chérigo, L., et al. Bacterial resistance modifying tetrasaccharide agents from Ipomoea murucoides. Phytochemistry 70, no. 2 (2009): 222–27.
Chérigo, L., et al. Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides. J Nat Prod 71, no. 6 (2008): 1037–45.
Chérigo, L., et al. Resin glycosides from the flowers of Ipomoea murucoides. J Nat Prod 69, no. 4 (2006): 595–99.
Cho, H. J., et al. Hexane/ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin. Food Chem 121 (2010): 959–66.
Chung, S. Y., et al. Potent modulation of P-glycoprotein activity by naturally occurring phenylbutenoids from Zingiber cassumunar. Phytother Res 23, no. 4 (2009): 472–76.
Chung, S. Y., et al. Potent modulation of P-glycoprotein-mediated resistance by kaempferol derivatives isolated from Zingiber zerumbet. Phytother Res 21, no. 6 (2007): 565–69.
Cinatl, J., et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361, no. 9374 (2003): 2045–46.
Cortés-Selva, F., et al. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania. Curr Pharm Des 11, no. 24 (2005): 3125–39.
Dao, T. T., et al. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett 21, no. 1 (2011): 294–98. E-pub (preprint) November 5, 2010.
Dong, Y., et al. The anti-respiratory syncytial virus (RSV) effect of radix glycyrrhizae in vitro. Zhong Yao Cai 27, no. 6 (2004): 425–27.
Efferth, T., et al. Complex interactions between phytochemicals: the multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12, no. 1 (2011): 122–32.
Elmadjian, F., et al. The action of mono-ammonium glycyrrhizinate on adrenalectomized subjects and its synergism with hydrocortisone. J Clin Endocrinol Metab 16, no. 3 (1956): 338–49.
Fiore, C., et al. Antiviral effects of Glycyrrhiza species. Phytother Res 22, no. 2 (2008): 141–48.
Follett, J., et al. Growing licorice (Glycyrrhiza glabra L.). New Zealand Center for Crop and Food Research broadsheet 121 (2000).
Foster, Steven. Licorice—Glycyrrhiza. Series of monographs on the website of Steven Foster. http://stevenfoster.com/education/monograph/licorice.html (accessed February 7, 2011).
Fuhrman, B., et al. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal 2, no. 3 (2000): 491–506.
Gao, X., et al. Review of pharmacological effects of Glycyrrhiza radix and its bioactive compounds. Zhongguo Zhong Yao Za Zhi 34, no. 21 (2009): 2695–700.
Grankina, V. P., et al. Trace element composition of Ural licorice Glycyrrhiza uralensis Fisch. (Fabaceae family). Contemp Probl Ecol 2, no. 4 (2009): 396–99.
Grover, I. S., et al. Effect of liquorice [Glycyrrhiza glabra Linn.] as an adjuvant in newly diagnosed sputum smear-positive patients of pulmonary tuberculosis on directly observed treatment short course (DOTS) therapy. Chest 130, no. 4, suppl. (2006): 95S.
Hammouda, F. M., et al. Glycyrrhiza glabra L. In A Guide to Medicinal Plants in North Africa, 147–50. Malaga, Spain: IUCN Center for Mediterranean Cooperation, 2005. http://uicnmed.org/nabp/database/HTM/PDF/p94.pdf.
Hayashi, H., et al. Field survey of Glycyrrhiza plants in central Asia (2). Characterization of phenolics and their variation in the leaves of Glycyrrhiza plants collected in Kazakhstan. Chem Pharm Bull (Tokyo) 51, no. 11 (2003): 1147–52.
He, J., et al. Antibacterial compounds from Glycyrrhiza uralensis. J Nat Prod 69 (2006): 121–24.
Hirabayashi, K., et al. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chem Pharm Bull (Tokyo) 39, no. 1 (1991): 112–15.
Hoever, G., et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 48, no. 4 (2005): 1256–59.
Irani, M., et al. Leaves antimicrobial activity of Glycyrrhiza glabra L. Iran J Pharm Res 9, no. 4 (2010): 425–28.
Janke, R.. Farming a few acres of herbs: licorice. MF-2616. Kansas State University, May 2004. ksre. ksu.edu/library/hort2/mf2616.pdf.
Johns, C. Glycyrrhizic acid toxicity caused by consumption of licorice candy cigars. CJEM 11, no. 1 (2009): 94–96.
Ko, H. C., et al. The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. J Ethnopharmacol 107, no. 2 (2006): 205–10.
Kolbe, L., et al. Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 298, no. 1 (2006): 23–30.
Kondo, K., et al. Constituent properties of licorices derived from Glycyrrhiza uralensis, G. glabra, or G. inflata identified by genetic information. Biol Pharm Bull 30, no. 7 (2007): 1271–77.
Kuo, K., et al. Water extract of Glycyrrhiza uralensis inhibited enterovirus 71 in a human foreskin fibroblast cell line. Am J Chin Med 37, no. 2 (2009): 383–94.
Kusano, Eiji. How to diagnose and treat a licorice-induced syndrome with findings similar to that of primary hyperaldosteronism. Intern Med 43, no. 1 (2004): 5–6.
Kushiev, H., et al. Remediation of abandoned saline soils using Glycyrrhiza glabra: a study from the Hungry Steppes of central Asia. Int J Agr Sust. 3, no. 2): 102, 2005.
Lapi, F., et al. Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products. Br J Clin Pharmacol 66, no. 4 (2008): 572–74.
León, I., et al. Pentasaccharide glycosides from the roots of Ipomoea murucoides. J Nat Prod 68, no. 8 (2005): 1141–46.
Li, X. L., et al. Antioxidant status and immune activity of glycyrrhiza in allergic rhinitis mice. Int J Mol Sci 12 (2011): 905–16.
Li, Y. S. Toxicity attenuation and efficacy potentiation effect of liquorice on treatment of rheumatoid arthritis with Tripterygium wilfodii. Zhongguo Zhong Xi Yi Jie He Za Zhi 26, no. 12 (2006): 1117–19.
Lin, J. C. Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res 59, no. 1 (2003): 41–47.
Liu, X. R., et al. Treatment of intestinal metaplasia and atypical hyperplasia of gastric mucosa with xiao wei yan powder. Zhongguo Zhong Xi Yi Jie He Za Zhi 12, no. 10 (1992): 602–3, 580.
Martin, M. D., et al. A controlled trial of a dissolving oral patch concerning glycyrrhiza (licorice) herbal extract for the treatment of aphthous ulcers. Gen Dent 56, no. 2 (2008): 206–10.
Moghadamnia, A. A. The efficacy of the bioadhesive patches containing licorice extract in the management of recurrent aphthous stomatitis. Phytother Res 23, no. 2 (2009): 246–50.
Molnár, J., et al. Reversal of multidrug resistance by natural substances from plants. Curr Top Med Chem 10, no. 17 (2010): 1757–68.
Morel, C., et al. Isoflavones as potentiators of antibacterial activity. J Agric Food Chem 51, no. 19 (2003): 5677–79.
Muralidharan, P., et al. Cerebroprotective effect of Glycyrrhiza glabra Linn. root extract on hypoxic rats. J Bangladesh Pharmacol Soc (BDPS) 4 (2009): 60–64.
Nagoshi, Chihiro. Synergistic effect of [10]-gingerol and aminoglycosides against vancomycin-resistant enterococci (VRE). Biol Pharm Bull 29, no. 3 (2006): 443–47.
Nomura, T., et al. Chemistry of phenolic compounds of licorice (Glycyrrhiza species) and their estrogenic and cytotoxic activities. Pure Appl Chem 74, no. 7 (2002): 1199–206.
Parsaeimehr, A., et al. Producing friable callus for suspension of culture in Glycyrrhiza glabra. Adv Enviro Biol 3, no. 2 (2009): 125–28.
Pati, A. K. Licorice (Glycyrrhiza glabra, G. uralensis). Press release from Best Nutrition Products, Inc., Hayward, Calif., July 10, 2010. On the website of PRLog at http://prlog.org/10780323-licorice-glycyrrhiza-glabra-uralensis-dr-abhay-kumar-pati-best-nutrition-hayward-ca-usa.html.
Pompei, R., et al. Antiviral activity of glycyrrhizic acid. Experientia 36, no. 3 (1980): 304.
Pompei, R., et al. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281, no. 5733 (1979): 689–90.
Pompei, R., et al. Glycyrrhizic acid inhibits virus growth in embryonated eggs. Microbiologica 6, no. 3 (1983): 247–50.
Räikkönen, K., et al. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am J Epidemiol 170, no. 9 (2009): 1137–46.
Renjie, L., et al. Protective effect of Glycyrrhiza glabra polysaccharides against carbon tetrachloride-induced liver injury in rats. Afr J Microbiol Res 4, no. 16 (2010): 1784–87.
Saeedi, M., et al. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat 14, no. 3 (2003): 153–57.
Saif, M. W., et al. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine 17, no. 3–4 (2010): 161–69.
Sancar, M., et al. Comparative effectiveness of Glycyrrhiza glabra vs. omeprazole and misoprostol for the treatment of aspirin-induced gastric ulcers. Afr J Pharm Pharmacol 3, no. 12 (2009): 615–20.
Sato, J., et al. Antifungal activity of plant extracts against Arthrinium sacchari and Chaetomium funicola. J Biosci Bioeng 90, no. 4 (2000): 442–46.
Sato, Y., et al. Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza uralensis roots, acts in the lower part of intestine. Biol Pharm Bull 30, no. 1 (2007): 145–49.
Schröfelbauer, B., et al. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling. Biochem J 421, no. 3 (2009): 473–82.
Shibata, S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120, no. 10 (2000): 849–62.
Shirazi, M., et al. An evaluation of antibacterial activity of Glycyrrhiza glabra extract on the growth of salmonella, shigella and ETEC E. coli. J Biol Sci 7 (2007): 827–29.
Simões, M., et al. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. J Nat Prod 26 (2009): 746–57.
Sofia, H. N., and T. M. Walter. Review of Glycyrrhiza glabra, Linn. Siddha Papers 02 (01) (LR). ISSN 0974-2522. January 12, 2009. http://openmed.nic.in/3195/01/Glycyrrhiza_final.pdf.
Stavri, M., et al. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemo 59 (2007): 1247–60.
Strandberg, T. E., et al. Birth outcome in relation to licorice consumption during pregnancy. Am J Epidemiol 153, no. 11 (2001): 1085–88.
Strandberg, T. E., et al. Preterm birth and licorice consumption during pregnancy. Am J Epidemiol 156, no. 9 (2002): 803–5.
Sui, X., et al. Antiviral effect of diammonium glycyrrhizinate and lithium chloride on cell infection by pseudorabies herpesvirus. Antiviral Res 85, no. 2 (2010): 346–53.
Sultana, S., et al. Antimicrobial, cytotoxic and antioxidant activity of methanolic extract of Glycyrrhiza glabra. Agr Biol J N America 1, no. 5 (2010): 957–60.
Tancevski, I., et al. Images in cardiovascular medicine. Malicious licorice. Circulation 117 (2008): e299.
Teelucksingh, S., et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic. Lancet 335, no. 8697 (1990): 1060–63.
Utsunomiya, T., et al. Glycyrrizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother 41, no. 3 (1997): 551–56.
Wagner, H., et al. Natural products chemistry and phytomedicine research in the new millennium: new developments and challenges. ARKIVOC 7 (2004): 277–84.
Wang, X. Q., et al. The anti-respiratory syncytial virus effect of active compound of Glycyrrhiza GD4 in vitro. Zhong Yao Cai 29, no. 7 (2006): 692–94.
Williamson, E. M., et al. Synergy: interactions within herbal medicines. Eur Phyto J 8, no. 5 (2001): 401–9.
Wolkerstoerfer, A., et al. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res 83, no. 2 (2009): 171–78.
Wu, T. H., et al. Hypouricemic effect and regulatory effects on autonomic function of shao-yao gan-cao tang, a Chinese herbal prescription, in asymptomatic hyperuricemic vegetarians. Rheumatol Int 28, no. 1 (2007): 27–31.
Yamashiki, M., et al. Effects of the Japanese herbal medicine “sho-saiko-to” (TJ-9) on interleukin-12 production in patients with HCV-positive liver cirrhosis. Dev Immunology 7, no. 1 (1999): 17–22.
Yasue, H., et al. Severe hypokalemia, rhabdomyolysis, muscle paralysis, and respiratory impairment in a hypertensive patient taking herbal medicines containing licorice. Intern Med 46, no. 9 (2007): 575–78.
Yim, S. B., et al. Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J Pharmacol Exper Therap 321, no. 2 (2007): 816.
Yuan, H. N., et al. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia. J Clin Psychopharmacol 28, no. 3 (2008): 264–370.
Zhang, L., et al. Study on adscription of plasma effective constituents of rat after administrated with Paeonia lacliflora and Glycyrrhiza uralensis. Zhongguo Zhong Yao Za Zhi 32, no. 17 (2007): 1789–91.
Alakurtti, S., et al. Pharmacological properties of the ubiquitous natural product betulin. Eur J Pharm Sci 1 (2006): 1–13.
Berry, A. M., et al. Bacteriohopanetetrol: abundant lipid in frankia cells and in nitrogen-fixing nodule tissue. Plant Physiol 95, no. 1 (1991): 111–15.
Bishop, J. G., et al. The effect of ceanothyn on blood coagulation time. J Am Pharm Ass 46, no. 7 (1957): 396–98.
Cichewicz, R. H. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 24, no. 1 (2004): 90–114.
Cook, William. Ceanothus americanus. Entry in The Physiomedical Dispensatory (1869). Electronic version hosted on the website of Medical Herbalism journal. http://medherb.com/cook/home.htm.
de Sá, M. S., et al. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice. Parasitol Res 105, no. 1 (2009): 275–79.
Delwiche, C. C., et al. Nitrogren fixation by Ceanothus. Plant Physiol 40, no. 6 (1965): 1045–47.
Eichenmüller, M., et al. Betulinic acid induces apoptosis and inhibits hedgehog signaling in rhabdomyosarcoma. Br J Cancer 103, no. 1 (2010): 43–51.
Emile, A., et al. Bioassay-guided isolation of antifungal alkaloids from Melochia odorata. Phytother Res 21, no. 4 (2007): 398–400.
Fisher, J. B., et al. What the towers don’t see at night: nocturnal sap flow in trees and shrubs at two AmeriFlux sites in California. Tree Physiol 27, no. 4 (2007): 597–610.
Fu, J. Y. Betulinic acid ameliorates impairment of endothelium-dependent relaxation induced by oxidative stress in rat aorta. Zhejiang Da Xue Xue Bao Yi Xue Ban 39, no. 5 (2010): 523–29.
Giordano, A. A. S., et al. Ceanothus americanus: its effect on the coagulation time of the blood. Arch Otolaryngol 7, no. 6 (1928): 618–22.
Groot, J. T., et al. The pharmacology of Ceanothus americanus. I. Preliminary studies: hemodynamics and the effects on coagulation. J Pharm Exper Therap 30, no. 4 (1926): 275–91.
Klein, F. K., et al. Ceanothus alkaloids. Americine. J Am Chem Soc 90, no. 9 (1968): 2398–404.
Kommera, H., et al. Synthesis and anticancer activity of novel betulinic acid and betulin derivatives. Arch Pharm (Weinheim) 343, no. 8 (2010): 449–57.
Laferriere, J. E., et al. Mineral composition of some traditional Mexican teas. Plant Food Hum Nutr 41 (1991): 277–82.
Lan, P., et al. Understanding the structure-activity relationship of betulinic acid derivatives as anti-HIV-1 agents by using 3D-QSAR and docking. J Mol Model 17, no. 7 (2011): 1643–59. E-pub (preprint) October 27, 2010.
Laszczyk, M. N. Pentacytic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75, no. 15 (2009): 1549–60.
Leal, I. C., et al. Ceanothane and lupane type triterpenes from Zizyphus joazeiro—an anti-staphylococcal evaluation. Planta Med 76, no. 1 (2010): 47–52.
Lee, S. M., et al. Anti-complementary activity of triterpenoides from fruit of Zizyphus jujuba. Biol Pharm Bull 27, no. 11 (2004): 1883–86.
Lee, S. S., et al. Preparation and cytotoxic effect of ceanothic acid derivatives. J Nat Prod 61, no. 11 (1998): 1343–47.
Li, X. C., et al. Antimicrobial compounds from Ceanothus americanus against oral pathogens. Phytochemistry 46, no. 1 (1997): 97–102.
Li, Y., et al. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Mol Carcinog 49, no. 7 (2010): 630–40.
Lo, Y. C. Betulinic acid stimulates the differentiation and mineralization of osteoblastic MC3T3-E1 cells: involvement of BMP/Runx2 and beta-catenin signals. J Agric Food Chem 58, no. 11 (2010): 6643–49.
Lucas, Joy. Ceanothus—a nice cup of tea & a piece of ague cake. Updated August 30, 2003. On the Homeopathic Materia Medica website at http://web.mac.com/joylucas/iWeb/Site/Materia%20Medica%20(2)_files/Ceanothus.pdf.
Lucero, M. E., et al. Composition of Ceanothus gregii oil as determined by stream distillation and solid-phase microextraction. J Essent Oil Res 22 (2010): 104–42.
Lynch, T. A., et al. An investigation of the blood coagulation principles from Ceanothus americanus. J Am Pharm Assoc Am Pharm Assoc (Baltimore) 47, no. 11 (1958): 816–19.
Moore, M. Ceanothus: red root. Folio on the website of the Southwest School of Botanical Medicine. http://www.swsbm.com/FOLIOS/RedRtFol.pdf (accessed December 21, 2011).
Rooney, R. F., et al. A case of poisoning from Ceanothus velutinus, resembling Rhus poisoning. Cal State J Med 3, no. 9 (1905): 290–91.
Roscoe, C. W., et al. A preliminary study of the alkaloidal principles of Ceanothus americanus and Ceanothus velutinus. J Am Pharm Assoc 49, no. 2 (1960): 108–12.
Saaby, L., et al. Isolation of immunomodulatory triterpene acids from a standardized rose hip powder (Rosa canina L.). Phytother Res 25, no. 2 (2011): 195–201. E-pub (preprint) 2010.
Salazar-Aranda, R., et al. Antimicrobial and antioxidant activities of plants from northeast of Mexico. Evid Based Complement Alternat Med e-pub (preprint) September 21, 2009.
Spjut, R. W. Ceanothus: Rhamnacea. On the website of World Botanical Associates. http://worldbotanical.com/ceanothus.htm (accessed December 9, 2010).
Steele, J. C., et al. In vitro and in vivo evaluation of betulinic acid as an antimalarial. Phytother Res 13, no. 2 (1999): 115–19.
Suksamram, S., et al. Ceanothane- and lupane-type triterpenes with antiplasmodial and antimycobacterial activities from Ziziphus cambodiana. Chem Pharm Bull (Tokyo) 54, no. 4 (2006): 535–37.
Takada, Y., et al. Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 171, no. 6 (2003): 3278–86.
Theraldsen, C. E., et al. Notes on blood reactions of the alkaloids of Ceanothus americanus. Am J Physiol 79, no. 3 (1926): 545–52.
Tschesche, R., et al. Alkaloids from Rhamnaceae. IV. Integerrin, an additional peptide alkaloid from Ceanothus integgerrimus Hock and Arn. Tetrahedron Lett 11 (1968): 1311–15.
Tschesche, R., et al. Integerressin and integerrenin, two peptide alkaloids from Ceanothus integerrimus Hook. and Arn. Chem Ber 100, no. 12 (1967): 3924–36.
Vijayan, V., et al. Betulinic acid inhibits endotoxin stimulated phosphorylation cascade and pro-inflammatory prostaglandin E(2) production in human peripheral blood mononuclear cells. Br J Pharmacol 162, no. 6 (2011): 1291–303. E-pub (preprint) 2010.
Wastle, H. Influence of tea leaves from Ceanothus americanus on blood pressure of hypertensive rats. Fed Proc 7, no. 1, part 1 (1948): 131.
Wollenweber, E., et al. Exudate flavonoids of eight species of Ceanothus (Rhamnaceae). Z Naturforsch C 59, no. 7–8 (2004): 459–62.
Yi, J. E. Immunomodulatory effects of betulic acid from the bark of white birch on mice. J Vet Sci 11, no. 4 (2010): 305–13.
Yogeeswari, P., et al. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12, no. 6 (2005): 657–66.
Yoon, J. J., et al. Betulinic acid inhibits high glucose-induced vascular smooth muscle cells proliferation and migration. J Cell Biochem 111, no. 6 (2010): 1501–11.
Yun, Y., et al. Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Arch Pharm Res 26, no. 12 (2003): 1087–95.
Ahmadi, K., et al. Ganoderma lucidum induces the expression of CD40/CD86 on peripheral blood monocytes. Iran J Immunol 6, no. 2 (2009): 87–91.
Babu, P. D., et al. The sacred mushroom “reishi”—a review. Am Eurasian J Botany 1, no. 3 (2008): 107–10.
Bao, X. F., et al. Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry 59, no. 2 (2002): 175–81.
Bhagwan, S. S., et al. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 10 (2009): 717–42.
Chan, W. K., et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med 11, no. 6 (2005): 1047–57.
Chan, W. K., et al. Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int Immunol 19, no. 7 (2007): 891–99.
Chang, Y. H., et al. Ganoderma lucidum extract promotes immune responses in normal BALB/c mice in vivo. In Vivo 23, no. 5 (2009): 755–59.
Chang, Y. H., et al. Ganoderma lucidum extracts inhibited leukemia WEHI-3 cells in BALB/c mice and promoted an immune response in vivo. Biosci Biotechnol Biochem 73, no. 12 (2009): 2589–94.
Chen, S. D., et al. Effects of fermentation products of Ganoderma lucidum on growth performance and immunocompetence in weanling pigs. Arch Anim Nutr 62, no. 1 (2008): 22–32.
Chen, W. C., et al. Effects of Ganoderma lucidum and krestin on subset T-cell in spleen of gamma-irradiated mice. Am J Chin Med 23, no. 3–4 (1995): 289–98.
Chen, W. Y., et al. Effect of reishi polysaccharides on human stem/progenitor cells. Bioorg Med Chem 18, no. 24 (2010): 8583–91.
Chen, X., et al. Monitoring of immune responses to a herbal immune-modulator in patients with advanced colorectal cancer. Int Immunopharmacol 6, no. 3 (2006): 499–508.
Cheng, C. H., et al. The effects of two different Ganoderma species (lingzhi) on gene expression in human monocytic THP-1 cells. Nutr Cancer 62, no. 5 (2010): 648–58.
Cheuk, W., et al. Regression of gastric large B-cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (lingzhi)? Int J Surg Pathol 15, no. 2 (2007): 180–86.
Eo, S. K., et al. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol 68, no. 1–3 (1999): 129–36.
Eo, S. K., et al. Possible mode of antiviral activity of acidic protein bound polysaccharides isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol 72, no. 3 (2000): 475–81.
Gao, Y., et al. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int J Med Mushrooms 5, no. 3 (2003): 20.
Gao, Y., et al. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32, no. 3 (2003): 201–15.
Gao, Y., et al. Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer. J Med Food 8, no. 2 (2005): 159–68.
Gill, S. K., et al. Toxicity of a traditional Chinese medicine, Ganoderma lucidum, in children with cancer. Can J Clin Pharmacol 15, no. 2 (2008): e275–85.
Hijikata, Y., et al. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med 13, no. 9 (2007): 985–87.
Hsu, H. Y., et al. Reishi immune-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells. J Cell Physiol 215, no. 1 (2008): 15–26.
Hsu, M. J., et al. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol 72, no. 1 (2002): 207–16.
Hsu, M. J., et al. Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br J Pharmacol 139, no. 2 (2003): 289–98.
Hsu, T. L., et al. Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins. J Biol Chem 284, no. 5 (2009): 34479–89.
Huang, S. Q., et al. Extraction of polysaccharide from Ganoderma lucidum and its immune enhancement activity. Int J Biol Macromol 47, no. 3 (2010): 336–41.
Huang, S. Q., et al. Optimization of alkaline extraction of polysaccharides from Ganoderma lucidum and their effect on immune function of mice. Molecules 15, no. 5 (2010): 3694–708.
Jeurink, P. V., et al. Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol 8, no. 8 (2008): 1124–33.
Ji, Z., et al. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol 112, no. 3 (2007): 445–50.
Kim, K. C., et al. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int J Mol Med 4, no. 3 (1999): 273–77.
Kim, Y. S., et al. Antiherpetic activities of acidic protein bound polysaccharides isolated from Ganoderma lucidum alone and in combinations with interferons. J Ethnopharmacol 72, no. 3 (2000): 451–58.
Kohguchi, M., et al. Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (rokkaku-reishi). Biosci Biotechnol Biochem 68, no. 4 (2004): 881–87.
Kuo, M. C., et al. Ganoderma lucidum mycelia enhance innate immunity by activating NF-kappaB. J Ethnopharmacol 103, no. 2 (2006): 217–22.
Li, W. J., et al. Ganoderma atrum polysaccharide induces antitumor activity via the mitochondrial apoptotic pathway related to activation of host immune response. J Cell Biochem e-pub (preprint) December 7, 2010.
Li, Y. Q., et al. Anti-hepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett 28, no. 11 (2006): 837–41.
Lin, J. Y., et al. Ganoderma tsugae in vivo modulates Th1/Th2 and macrophage responses in an allergic murine model. Food Chem Toxicol 44, no. 12 (2006): 2025–32.
Lin, K. L., et al. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J Biol Chem 281, no. 34 (2006): 24111–23.
Lin, Y. L., et al. An immunomodulatory protein, ling zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. J Leukoc Biol 86, no. 4 (2009): 877–89.
Lin, Y. L., et al. Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol 78, no. 2 (2005): 533–43.
Lin, Y. L., et al. Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice. Mol Pharmacol 70, no. 2 (2006): 637–44.
Lin, Z. B. Cellular and molecular mechanisms of immune-modulation by Ganoderma lucidum. J Pharmacol Sci 99, no. 2 (2005): 144–53.
Lin, Z. B., et al. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25, no. 11 (2004): 1387–95.
Moradali, M. F., et al. Investigation of potential antibacterial properties of methanol extracts from fungus Ganoderma applanatum. Chemotherapy 52, no. 5 (2006): 241–44.
Mothana, R. A., et al. Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 74, no. 1–2 (2003): 177–80.
Mothana, R. A., et al. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod 63, no. 3 (2000): 416–18.
Neidermeyer, T. H., et al. Antiviral terpenoid constituents of Ganoderma pfeifferi. J Nat Prod 68, no. 12 (2005): 1728–31.
Ofodile, L. N., et al. Antimicrobial activity of some Ganoderma species from Nigeria. Phytother Res 19, no. 4 (2005): 310–13.
Oh, K. W., et al. Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine. J Ethnopharmacol 72, no. 1–2 (2000): 221–27.
Quereshi, S., et al. Evaluation of antibacterial activity of different Ganoderma lucidum extracts. People’s J Scientif Res 3, no. 1 (2010): 9–13.
Russell, R., et al. Ganoderma—a therapeutic fungal biofactory. Phytochemistry 67, no. 18 (2006): 1985–2001.
Sanodiya, B. S., et al. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 10, no. 8 (2009): 717–42.
Shao, B. M., et al. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun 323, no. 1 (2004): 133–41.
Sliva, Daniel. Ganoderma lucidum in cancer research, Leukemia Res 30 (2006): 767–68.
Sliva, D., et al. Biological activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9, no. 4 (2003): 491–97.
Smania, E. F., et al. Antifungal activity of sterols and triterpenes isolated from Ganoderma annulare. Fitoterapia 74, no. 4 (2003): 375–77.
Smania, J. A., et al. Derivation does not influence antimicrobial and antifungal activities of applanoxicide acids and sterols from Ganoderma spp. Z Naturforsch C 61, no. 1–2 (2006): 31–34.
Spelman, K., et al. Traditional herbal remedies that influence cell adhesion molecule activity. Phytother Res 25, no. 4 (2011): 473–83. E-pub (preprint) November 23, 2010.
Stamets, P. Products for log and stump cultivation. On the website of Fungi Perfecti. http://www.fungi.com/plus/index.html (accessed January 30, 2012).
Sun, L. X., et al. Promoting effects of Ganoderma lucidum polysaccharides on B16F10 cells to activate lymphocytes. Basic Clin Pharmacol Toxicol 108, no. 3 (2011): 149–54. E-pub (preprint) October 22, 2010.
Volman, J. J., et al. Effects of mushroom-derived beta-glucan-rich polysaccharide extracts on nitric oxide production by bone marrow-derived macrophages and nuclear factor-kappaB transactivation in Caco-2 reporter cells: can effects be explained by structure? Mol Nutr Food Res 54, no. 2 (2010): 268–76.
Wachtel-Galor, S., et al. Ganoderma lucidum(“lingzhi”), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 91, no. 2 (2004): 263–69.
Wang, G., et al. Enhancement of IL-2 and IFN-gamma expression and NK cells activity involved in the anti-tumor effect of ganoderic acid Me in vivo. Int Immunopharmacol 7, no. 6 (2007): 864–70.
Wang, X., et al. Effects of Ganoderma lucidum polysaccharides on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull 30, no. 9 (2007): 1702–6.
Wang, X., et al. HPLC method for the determination and pharmacokinetic studies of four triterpenoids in rat plasma after oral administration of Ganoderma lucidum extract. Biomed Chromatogr 21, no. 4 (2007): 389–96.
Wasser, S. P. Reishi or ling zhi (Ganoderma lucidum). In Encyclopedia of Dietary Supplements, ed. P. M. Coates et al., 603–22. New York: Marcel Dekker, 2005. Reproduced online at http://alohamedicinals.com/reishi.pdf.
Xie, J. T., et al. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp Oncol 28, no. 1 (2006): 25–29.
Yeh, C. H., et al. Polysaccharides PS-G and protein LZ-8 from reishi (Ganoderma lucidum) exhibit diverse functions in regulating murine macrophages and T lymphocytes. J Agric Food Chem 58, no. 15 (2010): 8535–44.
Yin, G., et al. Chinese herbs (astragalus radix and Ganoderma lucidum) enhance immune response of carp, Cyprinos carpio, and protection against Aeromonas hydrophila. Fish Shellfish Immunol 26, no. 1 (2009): 140–45.
Yoon, S. Y., et al. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 17, no. 6 (1994): 438–42.
Yue, G. G., et al. Comparative studies of various Ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med 12, no. 8 (2006): 777–89.
Yuen, J. W., et al. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53, no. 1 (2005): 11–17.
Zhang, G. L., et al. Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice. World J Gastroenterol 8, no. 4 (2002): 728–33.
Zhang, J., et al. GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci 87, no. 19–22 (2010): 628–37.
Zhang, J. P., et al. Lipid extract from completely sporoderm-broken germinating Ganoderma sinensis spores elicits potent antitumor immune responses in human macrophages. Phytother Res 23, no. 6 (2009): 844–50.
Zhang, Y., et al. Effects of Ganoderma lucidum capsules on T lymphocytes subsets in football players on “living high-training low.” Br J Sports Med 42, no. 10 (2008): 819–22.
Zhao, H., et al. Enteric mucosal immune response might trigger the immunomodulation activity of Ganoderma lucidum polysaccharide in mice. Planta Med 76, no. 3 (2010): 223–27.
Zhou, G. Q., et al. Effect of Ganoderma lucidum polysaccharides on intestinal mucosal immune system in H22 liver cancer bearing mice. Zhongguo Zhong Xi Yi Jie He Za Zhi 29, no. 4 (2009): 335–39.
Zhou, X., et al. Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med 35, no. 4 (2007): 559–74.
Zhu, X. L., et al. Effects of Ganoderma lucidum polysaccharides on proliferation and cytotoxicity of cytokine-induced killer cells. Acta Pharmacol Sin 26, no. 9 (2005): 1130–37.
Abidoff, M., and Z. Ramazanov. Rhodiola rosea: the herbal heavyweight from Russia. Muscle Development (January 2003). http://vitalityplus.com.au/articles/RhodiolaPDF%20on%20Physical%20Performance.pdf.
Abidov, M., et al. Effect of extracts from Rhodiola rosea and Rhodiola crenulata (Crassulaceae) roots on ATP content in mitochondria of skeletal muscles. Bull Exp Biol Med 136, no. 6 (2003): 585–87.
Abidov, M., et al. Extract of Rhodiola rosea radix reduces the level of C-reactive protein and creatinine kinase in the blood. Bull Exp Biol Med 138, no. 1 (2004): 63–64.
Akgul, Y., et al. Lotaustralin from Rhodiola rosea roots. Fitoterapia 75, no. 6 (2004): 612–14.
An, F., et al. Determination of salidroside in eight Rhodiola species by TLC-UV spectrometry. Zhongguo Zhong Yao Za Zhi 23, no. 1 (1998): 43–44, 64.
Anonymous. Rhodiola. On the website of Paradise Herbs. http://paradiseherbs.com/media/uploads/research/Rhodiola.pdf (accessed February 8, 2012).
Anonymous. Rhodiola integrifolia Raf. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=RHINI (accessed December 10, 2010).
Anonymous. Rhodiola rhodantha. Entry in Plants for a Future database. http://www.pfaf.org/user/Plant.aspx?LatinName=Rhodiola+rhodantha (accessed December 21, 2011).
Anonymous. Rhodiola rhodantha. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=RHRH4 (accessed December 10, 2010).
Anonymous. Rhodiola rosea. Monograph. Altern Med Rev 7, no. 5 (2002): 421–23.
Anonymous. Rhodiola rosea. Wikipedia. http://en.Wikipedia.org/wiki/Rhodiola_rosea (accessed February 12, 2011).
Anonymous. Rhodiola rosea L. Entry in the Global Biodiversity Information Facility database. http://data.gbif.org/search/taxa/Rhodiola%20rosea (accessed December 10, 2010).
Anonymous. Rhodiola rosea L. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=RHRO3 (accessed December 10, 2010).
Anonymous. Study on the chemical constituents from Rhodiola bupleuroldes. Magazine abstract, October 10, 2008. http://jokefans.com/read.php/4735.htm.
Arora, R., et al. Evaluation of radioprotective activities Rhodiola imbricata Edgew—a high altitude plant. Mol Cell Biochem 273, no. 1–2 (2005): 209–23.
Aslanyan, G., et al. Double-blind, placebo-controlled, randomized study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine 17, no. 7 (2010): 494–99.
Battistelli, M., et al. Rhodiola rosea as antioxidant in red blood cells: ultrastructural and hemolytic behaviour. Eur J Histochem 49, no. 3 (2005): 243–54.
Bocharova, O. A., et al. The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research). Urol Nefrol (Moscow) 2 (1995): 46–47.
Brown, R. P., et al. Rhodiola rosea: a phytomedicinal overview. HerbalGram 56 (2002): 40–52.
Bystritsky, A., et al. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 14, no. 2 (2008): 175–80.
Calcabrini, C., et al. Rhodiola rosea ability to enrich cellular antioxidant defences of cultured human keratinocytes. Arch Dermatol Res 302, no. 3 (2010): 191–200.
Cao, L. L., et al. The effect of salidroside on cell damage induced by glutamate and intracellular free calcium in PC12 cells. J Asian Nat Prod Res 8, no. 1–2 (2006): 159–65.
Chem, X., et al. Hypoglycemic effect of Rhodiola sachalinensis A. Bor. polysaccharides: comparison of administration in different ways. Zhongguo Zhong Yao Za Zhi 21, no. 11 (1996): 685–87.
Chen, C. H., et al. Antioxidant activity of some plant extracts towards xanthine oxidase, lipoxygenase and tyrosinase. Molecules 14, no. 8 (2009): 2947–58.
Chen, Q. G., et al. The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine 16, no. 9 (2009): 830–38.
Chen, T. S., et al. Antioxidant evaluation of three adaptogen extracts. Am J Chin Med 36, no. 6 (2008): 1209–17.
Chen, X., et al. Protective effect of salidroside against H2O2-induced cell apoptosis in primary culture of rat hippocampal neurons. Mol Cell Biochem 332, no. 1–2 (2009): 85–93.
Cui, S., et al. Determination of p-tyrosol and salidroside in three samples of Rhodiola crenulata and one of Rhodiola kirilowii by capillary zone electrophoresis. Anal Bioanal Chem 377, no. 2 (2003): 370–74.
Darbinyan, V., et al. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry 61, no. 5 (2007): 343–48.
Darbinyan, V., et al. Rhodiola rosea in stress induced fatigue—a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 7, no. 5 (2000): 365–71.
De Bock, K., et al. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab 14, no. 3 (2004): 298–307.
De Sanctis, R., et al. In vitro protective effect of Rhodiola rosea extract against hypochlorous acid-induced oxidative damage in human erythrocytes. Biofactors 20, no. 3 (2004): 147–59.
Dieamant, G. C., et al. Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment. J Cosmet Dermatol 7, no. 2 (2008): 112–19.
Evdokimov, V. G., et al. Effect of cryopowder Rhodiola rosea L. on cardiorespiratory parameters and physical performance of humans. Aviakosm Ekolog Med 43, no. 6 (2009): 52–56.
Evstatieva, L., et al. Chemical composition of the essential oils of Rhodiola rosea L. of three different origins. Pharmacogn Mag 6, no. 24 (2010): 256–58.
Fan, W., et al. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo) 49, no. 4 (2001): 396–401.
Fintelmann, V., et al. Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies. Adv Ther 24, no. 4 (2007): 929–39.
Galambosi, B. Demand and availability of Rhodiola rosea L. raw material. Chapter 16 in Medicinal and Aromatic Plants, ed. R. J. Bogers et al., 223–36. Wageningen UR Frontis series, vol. 17. Springer, 2006.
Gao, D., et al. Antidiabetic potential of Rhodiola sachalinensis root extract in streptozotocin-induced diabetic rats. Methods Find Exp Clin Pharmacol 31, no. 6 (2009): 375–81.
Gauger, K. J., et al. Rhodiola crenulata inhibits the tumorigenic properties of invasive mammary epithelial cells with stem cell characteristics. J Med Plants Res 4, no. 6 (2010): 446–54.
Goel, H. C., et al. Radioprotection by Rhodiola imbricata in mice against whole-body lethal irradiation. J Med Food 9, no. 2 (2006): 154–60.
Grace, M. H., et al. Phytochemical characterization of an adaptogenic preparation from Rhodiola heterodonta. Nat Prod Commun 4, no. 8 (2009): 1053–58.
Guest, H. J. Molecular phylogeography of Rhodiola integrifolia (Crassulaceae) and its postglacial recolonization of north-western North America. Poster presented at the Botany 2006 conference at California State University at Chico, July 28–August 2, 2006. http://2006.botanyconference.org/engine/search/index.php?func=detail&aid=668.
Guest, H. J. Systematic and phylogeographic implications of molecular variation in the western North American roseroot, Rhodiola integrifolia (Crassulaceae). Master’s thesis, University of Victoria (British Columbia), 2001. http://hdl.handle.net/1828/2812.
Guo, Y. Synthesis, biological activity of salidroside and its analogues. Chem Pharm Bull (Tokyo) 58, no. 12 (2010): 1627–29.
Gupta, A., et al. Effects of Rhodiola imbricata on dermal wound healing. Planta Med 73, no. 8 (2007): 774–77.
Gupta, V., et al. Anti-oxidative effect of Rhodiola imbricata root extract in rats during cold, hypoxia and restraint (C-H-R) exposure and post-stress recovery. Food Chem Toxicol 48, no. 4 (2010): 1019–25.
Gupta, V., et al. A dose dependent adaptogenic and safety evaluation of Rhodiola imbricata Edgew, a high altitude rhizome. Food Chem Toxicol 46, no. 5 (2008): 1645–52.
Gupta, V., et al. Mechanism of action of Rhodiola imbricata Edgew during exposure to cold, hypoxia and restraint (C-H-R) stress induced hypothermia and post stress recovery in rats. Food Chem Toxicol 47, no. 6 (2009): 1239–45.
Ha, Z., et al. The effect of rhodiola and acetazolamide on the sleep architecture and blood oxygen saturation in men living at high altitude. Zhonghua Jie He He Hu Xi Za Zhi 25, no. 9 (2002): 527–30.
Hellum, B. H., et al. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med 76, no. 4 (2010): 331–38.
Huang, S. C., et al. Attenuation of long-term Rhodiola rosea supplementation on exhaustive swimming-evoked oxidative stress in the rat. Chin J Physiol 52, no. 5 (2009): 316–24.
Hung, S. K., et al. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine 18, no. 4 (2011): 235–44. E-pub (preprint) October 30, 2010.
Iaremiĭ, I. N., et al. Hepatoprotective properties of liquid extract of Rhodiola rosea. Eksp Klin Farmakol 65, no. 6 (2002): 57–59.
Jafari, M., et al. Rhodiola: a promising anti-aging Chinese herb. Rejuvenation Res 10, no. 4 (2007): 587–602.
Jang, S. L. Salidroside from Rhodiola sachalinensis protects neuronal PC12 cells against cytotoxicity induced by amyloid-beta. Immunopharmacol Immunotoxicol 25, no. 3 (2003): 295–304.
Jeong, H. J., et al. Neuraminidase inhibitory activities of flavonoids isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 17, no. 19 (2009): 6816–23.
Kang, S., et al. Comparative study of the constituents from 10 Rhodiola plants. Zhong Yao Cai 20, no. 12 (1997): 616–18.
Kanupriya., et al. Cytoprotective and antioxidant activity of Rhodiola imbricata against tert-butyl hydroperoxide induced oxidative injury in U-937 human macrophages. Mol Cell Biochem 275, no. 1–2 (2005): 1–6.
Kelly, G. S. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev 6, no. 3 (2001): 293–302.
Khanum, F., et al. Rhodiola rosea: a versatile adaptogen. Inst Food Tech 4 (2005): 55–62.
Kobayashi, K., et al. Constituents of Rhodiola rosea showing inhibitory effect on lipase activity in mouse plasma and alimentary canal. Planta Med 74, no. 14 (2008): 1716–19.
Kormosh, N., et al. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res 20, no. 5 (2006): 424–25.
Kucinskaite, A., et al. Evaluation of biologically active compounds in roots and rhizomes of Rhodiola rosea L. cultivated in Lithuania. Medicina (Kaunas) 43, no. 6 (2007): 487–494, 2007.
Kucinskaite, A., et al. Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina (Kaunas) 40, no. 7 (2004): 614–19.
Kwon, Y. I., et al. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension. Asia Pac J Clin Nutr 15, no. 3 (2006): 425–32.
Lee, F. T., et al. Chronic Rhodiola rosea extract supplementation enforces exhaustive swimming tolerance. Am J Chin Med 37, no. 3 (2009): 557–72.
Lee, M. W., et al. Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor. Arch Pharm Res 23, no. 5 (2000): 455–58.
Lei, Y., et al. Chemical composition of the essential oils of two Rhodiola species from Tibet. Z Naturforsch C 58, no. 3–4 (2003): 161–64.
Li, C., et al. Study on the extraction process for saldroside and p-tyrosol in Rhodiola crenulata. Zhong Yao Cai 29, no. 11 (2006): 1239–41.
Li, H. B., et al. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase. Eur J Pharmacol 588, no. 2–3 (2008): 165–69.
Li, H. X., et al. Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb, Rhodiola algida, on human peripheral blood monocytes. J Ethnopharmacol 123, no. 2 (2009): 257–66.
Li, J., et al. Effect of rhodiola on expressions of Flt-1, KDR and Tie-2 in rats with ischemic myocardium. Zhongguo Zhong Xi Yi Jie He Za Zhi 25, no. 5 (2005): 445–48.
Li, T., et al. Identification and comparative determination of rhodionin in traditional Tibetan medicinal plants of fourteen Rhodiola species by high-performance liquid chromatography-photodiode array detection and electrospray ionization-mass spectrometry. Chem Pharm Bull (Tokyo) 56, no. 6 (2008): 807–14.
Li, T., et al. Pharmacological studies on the sedative and hypnotic effect of salidroside from the Chinese medicinal plant Rhodiola sachalinensis. Phytomedicine 14, no. 9 (2007): 601–4.
Li, X., et al. Bioactive constituents from Chinese natural medicines. XXIX. Monoterpene and monoterpene glycosides from the roots of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo) 56, no. 4 (2008): 612–15.
Liu, Q., et al. Phenolic components from Rhodiola dumulosa. Zhongguo Zhong Yao Za Zhi 33, no. 4 (2008): 411–13.
Lovieno, N., et al. Second-tier natural antidepressants: review and critique, J Affect Disord 130, no. 3 (2011): 343–57. E-pub (preprint) June 26, 2010.
Luo, D., et al. Studies on the chemical constituents from Rhodiola dumulosa (I). Zhong Yao Cai 28, no. 2 (2005): 98–99.
Ma, G., et al. Rhodiolosides A–E, monoterpene glycosides from Rhodiola rosea. Chem Pharm Bull (Tokyo) 54, no. 8 (2006): 1229–33.
Majewska, A., et al. Antiproliferative and antimitotic effect, S phase accumulation and induction of apoptosis and necrosis after treatment of extract from Rhodiola rosea rhizomes on HL-60 cells. J Ethnopharmacol 103, no. 1 (2006): 43–52.
Maslov, L. N., et al. Antiarrhythmic activity of phytoadaptogens in short-term ischemia-reperfusion of the heart and postinfarcation cardiosclerosis. Bull Exp Biol Med 147, no. 3 (2009): 331–34.
Maslova, L. V., et al. The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress. Eksp Klin Farmakol 57, no. 6 (1994): 61–63.
Mattioli, L., et al. Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats. J Psychopharmacol 23, no. 2 (2009): 130–42.
Mattioli, L., et al. Rhodiola rosea L. extract reduces stress- and CRF-induced anorexia in rats. J Psychopharmacol 21, no. 7 (2007): 742–50.
Meng, L. Q., et al. Effection of observation Xinnaoxin capsules in treatment of chronic cerebral circulatory insufficiency. Zhongguo Zhong Yao Za Zhi 32, no. 17 (2007): 1798–800.
Ming, D. S., et al. Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 19, no. 9 (2005): 740–43.
Mishra, K. P., et al. Adjuvant effect of aqueous extract of Rhodiola imbricata rhizome on the immune responses to tetanus toxoid and ovalbumin in rats. Immunopharmacol Immunotoxicol 32, no. 1 (2010): 141–46.
Mishra, K. P., et al. Aqueous extract of Rhodiola imbricata rhizome inhibits proliferation of an erythroleukemic cell line K-562 by inducing apoptosis and cell cycle arrest at G2/M phase. Immunobiology 213, no. 2 (2008): 125–31.
Mishra, K. P., et al. Aqueous extract of Rhodiola imbricata rhizome stimulates proinflammatory mediators via phosphorylated IkappaB and transcription factor nuclear factor-kappaB. Immunopharmacol Immunotoxicol 28, no. 2 (2006): 201–12.
Mishra, K. P., et al. Aqueous extract of Rhodiola imbricata rhizome stimulates Toll-like receptor 4, granzyme-B and Th1 cytokines in vitro. Immunobiology 214, no. 1 (2009): 27–31.
Mook-Jung, I., et al. Neuroprotective effects of constituents of the Oriental crude drugs, Rhodiola sacra, R. sachalinensis and tokaku-joki-to, against beta-amyloid toxicity, oxidative stress and apoptosis. Biol Pharm Bull 25, no. 8 (2002): 1101–4.
Moran, R. V. Rhodiola integrifolia. In Flora of North America 8, ed. Flora of North America Steering Committee, 164–66. New York and Oxford, 2009. http://efloras.org/florataxon.aspx?flora_id=1&taxon_id=250092043.
Morgan, M., et al. Rhodiola rosea— rhodiola. Chem Pharm Bull (Tokyo) 47 (2005): 1–4.
Nakamura, S., et al. Bioactive constituents from Chinese natural medicines. XXXVI. Chemical structures and hepatoprotective effects of constituents from roots of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo) 55, no. 10 (2007): 1505–11.
Nakamura, S., et al. Bioactive constituents from Chinese natural medicines. XXXVIII. Chemical structures of acyclic glycosides from the roots of Rhodiola crenulata. Chem Pharm Bull (Tokyo) 56, no. 4 (2008): 536–40.
Narimanian, M., et al. Impact of Chisan (ADAPT-232) on the quality-of-life and its efficacy as an adjuvant in the treatment of acute non-specific pneumonia. Phytomedicine 12, no. 10 (2005): 723–29.
Olsson, E. M., et al. A randomized, double-blind, placebo-controlled, parallel-group study of the standardized extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med 75, no. 2 (2009): 105–12.
Pae, H. O., et al. Rhodiola sachalinesis induces the expression of inducible nitric oxide synthase gene by murine fetal hepatocytes (BNL CL. 2). Immunopharmacol Immunotoxicol 23, no. 1 (2001): 25–33.
Panossian, A., et al. Comparative study of Rhodiola preparations on behavioral despair of rats. Phytomedicine 15, no. 1–2 (2008): 84–91.
Panossian, A., et al. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 4, no. 3 (2009): 198–219.
Panossian, A., et al. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine 17, no. 7 (2010): 481–93.
Parisi, A., et al. Effects of chronic Rhodiola rosea supplementation on sport performance and antioxidant capacity in trained male: preliminary results. J Sports Med Phys Fitness 50, no. 1 (2010): 57–63.
Pashkevich, I. A., et al. Comparative evaluation of effects of p-tyrosol and Rhodiola rosea extract on bone marrow cells in vivo. Eksp Klin Farmakol 66, no. 4 (2003): 50–52.
Peng, J. N., et al. Chemical constituents of Rhodiola kirilowii (Regel) Regel. Zhongguo Zhong Yao Za Zhi 19, no. 11 (1994): 676–77, 702.
Peng, J. N., et al. Studies on the chemical constituents of Rhodiola fastigita. Yao Xue Xue Bao 31, no. 10 (1996): 798–800.
Pererva, T. P., et al. Interaction of Ungernia victoris, Rhodiola rosea and Polyscias filicifolia plant extracts with bacterial cells. Tsitol Genet 44, no. 4 (2010): 34–40.
Perfumi, M., et al. Adaptogenic and central nervous sytem effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice. Phytother Res 21, no. 1 (2007): 37–43.
Pickut, W. The uses of the Rhodiola integrifolia herb. LIVESTRONG.com, July 13, 2010. http://livestrong.com/article/173782-the-uses-of-the-rhodiola-integrifolia-herb/.
Platikanov, S., et al. Introduction of wild golden root (Rhodiola rosea L.) as a potential economic crop in Bulgaria. Econ Bot 20, no. 10 (2008): 1–7.
Pooja., et al. Anti-inflammatory activity of Rhodiola rosea—“a second-generation adaptogen.” Phytother Res 23, no. 8 (2009): 1099–102.
Qin, Y. J., et al. Effects of Rhodiola rosea on level of 5-hydroxytryptamine, cell proliferation and differentiation, and number of neuron in cerebral hippocampus of rats with depression induced by chronic mild stress. Zhongguo Zhong Yao Za Zhi 33, no. 23 (2008): 2842–46.
Qu, Z. Q., et al. Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implications of anti-oxidative and neuroprotective effects. Biomed Environ Sci 22, no. 4 (2009): 318–26.
Rohloff, J., et al. Volatiles from rhizomes of Rhodiola rosea L. Phytochemistry 59, no. 6 (2002): 655–61.
Ruan, X., et al. Analysis on the trace element and amino acid content in xinjiang 6 series Rhodiola L. plant. Guang Pu Xue Yu Guang Pu Fen Xi 21, no. 4 (2001): 542–44.
Schittko, U., and J. Grann. Rhodiola integrifolia: hybrid origin and medicinal ancestry. In Proceedings of the North Dakota Academy of Science, April 2008. Available online on the CBS Interactive website at http://findarticles.com/p/articles/mi_hb253/is_62/ai_n29437249/.
Schriner, S. E., et al. Decreased mitochondrial superoxide levels and enhanced protection against paraquat in Drosophila melanogaster supplemented with Rhodiola rosea. Free Radic Res 43, no. 9 (2009): 836–43.
Schriner, S. E., et al. Protection of human cultured cells against oxidative stress by Rhodiola rosea without activation of antioxidant defenses. Free Radic Biol Med 47, no. 5 (20009): 577–84.
Schutgens, F. W., et al. The influence of adaptogens on ultraweak biophoton emission: a pilot-experiment. Phytother Res 23, no. 8 (2009): 1103–8.
Seikou, N., et al. Bioactive constituents from Chinese natural medicines. XXVI. Chemical structures and hepatoprotective effects of constituents from roots of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo) 55, no. 10 (2007): 1505–11.
Seo, W. G., et al. The aqueous extract of Rhodiola sachalinensis root enhances the expression of inducible nitric oxide synthase gene in RAW264.7 macrophages. J Ethnopharmacol 76, no. 1 (2001): 119–23.
Shen, W., et al. Effects of rhodiola on expression of vascular endothelial cell growth factor and angiogenesis in aortic atherosclerotic plaque of rabbits. Zhongguo Zhong XI Yi Jie He Za Zhi 28, no. 11 (2008): 1022–5.
Shevtsov, V. A., et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 19, no. 2–3 (2003): 95–105.
Shi, C. D., et al. Automatic nervous system mediates the cardiovascular effects of Rhodiola sacra radix in rats. J Ethnopharmacol 119, no. 2 (2008): 284–90.
Sio-Po, I., et al. Association of free radicals and the tissue renin-angiotensin system: prospective effects of Rhodiola, a genus of Chinese herb, on hypoxia-induced pancreatic injury, JOP 2, no. 1 (2001): 16–25.
Skopinska-Rózewska, E., et al. The effect of Rhodiola quadrafida extracts on cellular immunity in mice and rats. Pol J Vet Sci 11, no. 2 (2008): 105–11.
Skopinska-Rózewska, E., et al. The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice. Pol J Vet Sci 11, no. 2 (2008): 97–104.
Smith, H. I. Materia medica of the Bella Coola and neighboring tribes of British Columbia. In Annual report for 1927, bulletin no. 56 of the Canada Department of Mines and the National Museum of Canada, 47–68. Ottawa: F. A. Acland, 1929. Reproduced online at http://wolf.mind. net/swsbm/Ethnobotany/Bella_Coola_Materia_Medica.pdf.
Spasov, A. A., et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7, no. 2 (2000): 85–89.
Spasov, A. A., et al. The effect and preparation rodakson on the psychophysiological and physical adaptation of students to an academic load. Eksp Klin Farmakol 63, no. 1 (2000): 76–78.
Tan, C. B., et al. Protective effect of salidroside on endothelial cell apoptosis induced by cobalt chloride. Biol Pharm Bull 32, no. 8 (2009): 1359–63.
Tolonen, A., et al. Phenylpropanoid glycosides from Rhodiola rosea. Chem Pharm Bull (Tokyo) 51, no. 4 (2003): 467–70.
Tu, Y., et al. Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines. J Med Food 11, no. 3 (2008): 413–23.
van Diermen, D., et al. Monoamine oxidase inhibition by Rhodiola rosea L. roots. J Ethnopharmacol 122, no. 2 (2009): 397–401.
Walker, T. B., et al. Does Rhodiola rosea possess ergogenic properties? Int J Sport Nutr Exerc Metab 16, no. 3 (2006): 305–15.
Wang, H., et al. The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against Coxsackievirus B3. Phytomedicine 16, no. 2–3 (2009): 146–55.
Wang, Q., et al. Salidroside protects the hypothalamic-pituitary-gonad axis of male rats undergoing negative psychological stress in experimental navigation and intensive exercise. Zhongua Nan Ke Xue 15, no. 4 (2009): 331–36.
Wiedenfeld, H., et al. Phytochemical and analytical studies of extracts from Rhodiola rosea and Rhodiola quadrifida. Pharmazie 62, no. 4 (2007): 308–11.
Wójcik, R., et al. The effect of Chinese medicinal herb Rhodiola kirilowii extracts on cellular immunity in mice and rats. Pol J Vet Sci 12, no. 3 (2009): 399–405.
Wong, Y. C., et al. Chemical constituents and anti-tuberculosis activity of root of Rhodiola kirilowii. Zhongguo Zhong Yao Za Zhi 33, no. 13 (2008): 1561–65.
Wu, T., et al. Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur J Pharmacol 613, no. 1–3 (2009): 93–99.
Wu, Y. L., et al. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. J Pharm Pharmacol 61, no. 10 (2009): 1375–82.
Xu, K. J., et al. Preventive and treatment effect of composite rhodiolae on acute lung injury in patients with severe pulmonary hypertension during extracorporeal circulation. Zhongguo Zhong Xi Yi Jie He Za Zhi 23, no. 9 (2003): 648–50.
Yan, X., et al. Seasonal variations in biomass and salidroside content in roots of Rhodiola sachalinensis as affected by gauze and red film shading. Ying Yong Sheng Tai Xue Bao 15, no. 3 (2004): 382–86.
Yoshikawa, M., et al. Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et May. (Crassulaceae). Chem Pharm Bull (Tokyo) 44, no. 11 (1996): 2086–91.
Yoshikawa, M., et al. Bioactive constituents of Chinese natural medicines. IV. Rhodiolae radix. (2). On the histamine release inhibitors from the underground part of Rhodiola sacra (Prain ex Hamet) S. H. Fu (Crassulaceae): chemical structures of rhodiocyanoside D and sacranosides A and B. Chem Pharm Bull (Tokyo) 45, no. 9 (1997): 1498–503.
Yoshikawa, M., et al. Rhodiocyanosides A and B, new antiallergic cyanoglycosides from Chinese natural medicine “si lie hong jing tain,” the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. Chem Pharm Bull (Tokyo) 43, no. 7 (1995): 1245–47.
Yousef, G. G., et al. Comparative phytochemical characterization of three Rhodiola species. Phytochemistry 67 (2006): 2380–91.
Yu, S., et al. Involvement of ERK1/2 pathway in neuroprotection by salidroside against hydrogen peroxide-induced apoptotic cell death. J Mol Neurosci 40, no. 3 (2010): 321–31.
Yu, S., et al. Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation. Cell Mol Neurobiol 28, no. 8 (2008): 1067–78.
Zhang, J., et al. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol 607, no. 1–3 (2009): 6–14.
Zhang, L., et al. Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 57, no. 5 (2010): 547–55.
Zhang, L., et al. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur J Pharmacol 564, no. 1–3 (2007): 18–25.
Zhang, S., et al. Early use of Chinese drug rhodiola compound for patients with post-trauma and inflammation in prevention of ALI/ARDS. Zhonghua Wai Ke Za Zhi 37, no. 4 (1999): 238–40.
Zhang, S., et al. Extraction of flavonoids from Rhodiola sachlinesis A. Bor by UPE and the antioxidant activity of its extract. Nat Prod Res 22, no. 2 (2008): 178–87.
Zhang, W. S., et al. Protective effects of salidroside on injury induced by hypoxia/hypoglycemia in cultured neurons. Zhongguo Zhong Yao Za Zhi 29, no. 5 (2004): 459–62.
Zhang, Z., et al. The effect of rhodiola capsules on oxygen consumption of myocardium and coronary artery blood flow in dogs. Zhongguo Zhong Yao Za Zhi 23, no. 2 (1998): 104–6.
Zhao, H. W., et al. Rhodiola sacra aqueous extract (RSAE) improves biochemical and sperm characteristics in cryopreserved boar semen. Theriogenology 71, no. 5 (2009): 849–57.
Zhou, X., et al. Rhodiola sachalinensis suppresses T241 fibrosarcoma tumor cells proliferation in vitro and growth in vivo. Zhong Yao Cai 31, no. 9 (2008): 1377–80.
Zhou, X., et al. Salidroside production by hairy roots of Rhodiola sachalinensis obtained after transformation with Agrobacterium rhizogenes. Biol Pharm Bull 30, no. 3 (2007): 439–42.
Zhu, B. W., et al. Reduction of noise-stress-induced physiological damage by radices of astragali and rhodiolae: glycogen, lactic acid and cholesterol contents in liver of the rat. Biosci Biotechnol Biochem 67, no. 9 (2003): 1930–36.
Zhu, B. W., et al. Resistance imparted by traditional Chinese medicines to the acute change of glutamic pyruvic transaminase, alkaline phosphatase and creatine kinase activities in rat blood caused by noise. Biosci Biotechnol Biochem 68, no. 5 (2004): 1160–63.
Zhu, L., et al. Prevention of Rhodiola–Astragalus membranaceus compounds against simulated plateau hypoxia brain injury in rat. Space Med Med Eng (Beijing) 18, no. 4 (2005): 303–5.
Zhuravlev, Y. N., et al. Medicinal plants of the Kurile Islands. Botanical News from the Russian Far East 2 (2005): 1–2.
Zubeldia, J. M., et al. Exploring new applications for Rhodiola rosea: can we improve the quality of life of patients with short-term hypothyroidism induced by hormone withdrawal? J Med Food 13, no. 6 (2010): 1287–92.
Zuo, G., et al. Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease. Antiviral Res 76, no. 1 (2007): 86–92.
Adeniyi, S. A., et al. Preliminary phytochemical analysis and insecticidal activity of ethanolic extracts of four tropical plants (Vernonia amygdalina, Sida acuta, Ocimum gratissimum and Telfaria occidentalis) against beans weevil (Acanthscelides obtectus). Int J Phys Sci 5, no. 6 (2010): 753–62.
Agyarko, K., et al. Metal levels in some refuse dump soils and plants in Ghana. Plant Soil Environ 56, no. 5 (2010): 244–51.
Ahmed, F., et al. Cryptolepine, isolated from Sida acuta, sensitizes human gastric adenocarcinoma cells to TRAIL-induced apoptosis. Phytother Res 25, no. 1 (2011): 147–50. E-pub (preprint) 2010.
Ahmed, M. U. Cyclopropenoid fatty acids in seed oils of Sida acuta and Sida rhombifolia (Malvaceae). J Am Oil Chem Sci 53, no. 11 (1976): 698–99.
Alesiani, D., et al. Identification of phenolic compounds from medicinal and melliferous plants and their cytotoxic activity in cancer cells. Caryologia 60, no. 1–2 (2007): 90–95.
Ananil, K., et al. Investigation of medicinal plants of Togo for antiviral and antimicrobial activities. Pharm Biol 38, no. 1 (2000): 40–45.
Anonymous. Country mallow. Brief profile on the HolisticOnLine.com website. http://holistic-online.com/herbal-med/_Herbs/h129.htm (accessed January 9, 2011).
Anonymous. Country mallow. Entry in the Oshims. com herb directory. http://oshims.com/herb-directory/c/country-mallow (accessed January 9, 2011).
Anonymous. Ethnobotanical uses: Sida acuta. Dr. Duke’s Phytochemical and Ethnobotanical Databases, online at http://ars-grin.gov/duke (accessed November 20, 2010).
Anonymous. Gulipas: Sida cordifolia Linn. Brief profile in Philippine Medicinal Plants database hosted on the StuartXchange.org website, updated November 2011. http://stuartxchange.org/Gulipas.html.
Anonymous. Nagabala. Brief profile on the HolisticOnLine.com website. http://holistic-online.com/herbal-med/_Herbs/h_sida-spinosa.htm (accessed January 9, 2011).
Anonymous. Sida acuta. Entry in the Listing of Interesting Plants of the World, on the Australian New Crops website. http://newcrops.uq.edu.au/listing/species_pages_S/Sida_acuta.htm (accessed November 15, 2010).
Anonymous. Sida acuta. Entry in the Pacific Island Ecosystems at Risk (PIER) database, updated December 27, 2010. http://hear.org/pier/species/sida_acuta.htm.
Anonymous. Sida acuta. Ethnobotanical Garden forum on the Shroomery Message Board. http://shroomery.org/forums/showflat.php/Number/945022 (accessed January 9, 2011).
Anonymous. Sida acuta Burm. f. Brief profile on website of Globinmed (Global Information Hub on Integrated Medicine). http://globinmed.com/index.php?option=com_content&view=article&id=79111:sida-acuta-burm-f&catid=721:s (accessed November 15, 2010).
Anonymous. Sida L. Entry in the U.S. Department of Agriculture Natural Resources Conservation Service PLANTS Database. http://plants.usda.gov/java/profile?symbol=SIDA (accessed November 15, 2010).
Anonymous. Sida rhombifolia. Brief profile on the website of Shaman Australis Botanicals. http://shaman-australis.com.au/shop/index.php?cPath=21_35_108 (accessed November 20, 2010).
Anonymous. Sida rhombifolia L.—Malvaceae. Chemicals and activities of the plant as given in Dr. Duke’s Phytochemical and Ethnobotanical Databases, online at http://ars-grin.gov/duke (accessed November 20, 2010).
Anonymous. Taxon: Sida acuta Burm. f. Entry in the USDA Germplasm Resources Information Network (GRIN) database. http://www.arsgrin.gov/cgi-bin/npgs/html/taxon.pl?33885 (accessed November 20, 2010).
Assam, J. P., et al. In vitro antibacterial activity and acute toxicity studies of aqueous-methanol extract of Sida rhombifolia Linn. (Malvaceae). BMC Complement Alt Med 10, no. 40 (2010): 1–7.
Balakrishnan, V., et al. Ethanoveterinary studies amoung farmers in Dindigul District Tamil Nadu, India. Global J Pharm 3, no. 1 (2009): 15–23.
Banzouzi, J.-T., et al. Studies on medicinal plants of Ivory Coast: investigation of Sida acuta for in vitro antiplasmodial activities and identification of an active constituent. Phytomed Int J Phytother Phytopharm 11, no. 4 (2004): 338–41.
Bhawani, S. A., et al. Thin-layer chromatographic analysis of steroids: a review. Trop J Pharm Res 9, no. 3 (2010): 301–13.
Bonjean, K., et al. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma. Biochemistry 37, no. 15 (1998): 5136–46.
Cao, J. H., et al. Studies of the chemical constituents of the herb huanghuaren (Sida acutá Burm. f.). Zhongguo Zhong Yao Za Zhi 18, no. 11 (1993): 681–703.
Chowdhury, A., et al. Phytochemical and biological investigations of Sida rhomboidea Linn. Internet J Alt Med 7, no. 2 (2009): 1–10.
Darwish, F. M. M., et al. Ecdysteroids and other constituents from Sida spinosa. Phytochemistry 62, no. 8 (2003): 1179–84.
Datusalia, A. K., et al. Antidepressant-like potential of Sida tiagii Bhandari fruits in mice. J Health Sci 55, no. 4 (2009): 641–48.
Datusalia, A. K., et al. Anxiolytic and antiseizure effects of Sida tiagii Bhandri. J Health Sci 54, no. 5 (2008): 544–50.
Dinan, L., et al. Phytoecdysteroid profiles in seeds of Sida spp. (Malvaceae). Phytochem Anal 12, no. 2 (2001): 110–19.
Edeoga, H. O., et al. Phytochemical constituents of some Nigerian medicinal plants. Afr J Biotechnol 4, no. 7 (2005): 685–88.
Ediriweera, E.R.H.S.S. A review of medicinal uses of weeds in Sri Lanka. Tropical Agricultural Research & Extension (Sri Lanka) 10 (2007): 11–16. http://sljol.info/index.php/TARE/article/viewFile/1865/1556.
Ekor, M., et al. Comparative evaluation of the protective effect of the ethanolic and methanolic leaf extracts of Sida acuta against hyperglycaemia and alterations of biochemical and haematological indices in alloxan diabetic rats. J Pharmacol Toxicol 5 (2010): 1–12.
Ekpo, M. A., et al. Antimicrobial activity of ethanolic and aqueous extracts of Sida acuta on microorganisms from skin infections. J Med Plant Res 3, no. 9 (2009): 621–24.
Flanagan, G. J., et al. The successful biological control of spinyhead sida, Sida acuta [Malvaceae], by Calligrapha pantherina (Col: Chrysomelidae) in Australia’s Northern Territory. In Proceedings of the X International Symposium on Biological Control of Weeds, July 4–14, 1999, ed. Neal R. Spencer, 35–41. Bozeman: Montana State University, 2000.
Gupta, A. K., et al. Phytoextraction capacity of the plants growing on tannery sludge dumping sites. Bioresour Technol 98, no. 9 (2007): 1788–94.
Hudson, J. B., et al. Further investigations on the antiviral activities of medicinal plants of Togo. Pharm Biol 38, no. 1 (2000): 46–50.
Idu, M., et al. Ethnobotanical plants used for oral healthcare among the Esan tribe of Edo State, Nigeria. Ethnobotanical Leaflets 13 (2009): 548–63.
Idu, M., et al. Ethnobotanical uses of plants among the Binis in the treatment of ophthalmic and ENT (ear, nose and throat) ailments. Ethnobotanical Leaflets 13 (2009): 480–503.
Iroha, I. R., et al. Evaluation of the antibacterial activity of extracts of Sida acuta against clinical isolates of Staphyloccocus aureus isolated from human immunodeficiency virus/acquired immunodeficiency syndrome patients. Res J Pharmocol 3, no. 2 (2009): 22–25.
Jang, D. S., et al. Compounds obtained from Sida acuta with the potential to induce quinone reductase and to inhibit 7,12-dimethylbenz[a] anthracene-induced preneoplastic lesions in a mouse mammary organ culture model. Arch Pharm Res 26, no. 8 (2003): 585–90.
Karou, D., et al. Antibacterial activity of alkaloids from Sida acuta. Afr J Biotechnol 5, no. 2 (2006): 195–200.
Karou, D., et al. Antimalarial activity of Sida acuta Burm. f. (Malvaceae) and Pterocarpus erinaceus Poir. (Fabaceae). J Ethnopharm 89 (2003): 291–94.
Karou, S. D., et al. Sida acuta Burm. f.: a medicinal plant with numerous potencies. Afr J Biotechnol 6, no. 25 (2007): 2953–59.
Khan, M. H., et al. Herbal remedies of asthma in Thoubal District of Manipur in north east India. Indian J Nat Prod Res 1, no. 1 (2010): 80–84.
Khatoon, S., et al. HPTLC method for chemical standardization of Sida species and estimation of the alkaloid ephedrine. J Planar Chromato 18 (2005): 364–67.
Kiessoun, K., et al. Polyphenol contents, antioxidant and anti-inflammatory activities of six Malvaceae species traditionally used to treat hepatitis B in Burkina Faso. Eur J Sci Res 44, no. 4 (2010): 570–580, 2010.
Leonard, D. B. Medicine at your feet: healing plants of the Hawaiian kingdom. Sida rhombifolia (huang hua mu). 2008. http://medicineatyourfeet.com/Sida_rhombifolia.pdf.
Londonkar, R. L., et al. Phytochemical and contraceptive property of Sida acuta Burm. f. Ind. in albino rats. Int J PharmTech Res 1, no. 4 (2009): 1260–66.
Malairajan, P., et al. Analgesic activity of some Indian medicinal plants J Ethnopharmacol 106, no. 3 (2006): 425–28.
Malairajan, P., et al. Antiulcer activity of Sida acuta Burm. Nat Prod Sci 12, no. 3 (2006): 150–52.
Matsut, T. A., et al. The plant alkaloid cryptolepine induces p21 and cell cycle arrest in a human osteosarcoma cell line. Int J Oncol 31 (2007): 915–22.
Mishra, M. P. Traditional-ethnoherbological and medicinal properties of Sida plant. On the website Ecosensorium.org, November 4, 2009. http://ecosensorium.org/2009/11/traditional-ethnoherbological-and.html.
Mott, J. J., et al. Germination and establishment of the weeds Sida acuta and Pennisetum pedicellatum in the Northern Territory. Australian J Exper Agr Animal Husb 20, no. 105 (1980): 463–69.
Nguyen-Pouplin, J., et al. Antimalarial and cytotoxic activities of ethnopharmacologically selected medicinal plants from south Vietnam. J Ethnopharm 109 (2007): 417–27.
Oboh, I. E., et al. Antimicrobial activity of the ethanol extract of the aerial parts of Sida acuta Burm. f. (Malvaceae). Trop J Pharm Res 6, no. 4 (2007): 809–13.
Ogie-Odia, E. A., et al. Assessment of some therapeutic plants of the Abbi People in Ndokwa West L.G.A. of Delta State, Nigeria. Ethnobotanical Leaflets 13 (2009): 989–1002.
Orech, F. O., et al. Potential toxicity of some traditional leafy vegetables consumed in Nyang’Oma Division, western Kenya. Afr J Food Nutr Sci 5, no. 1 (2005): 1–13.
Otero, R., et al. Snakebites and ethnobotany in the northwest region of Colombia. Part II. Neutralization of lethal and enzymatic effects of Bothrops atrox venom. J Ethnopharmacol 71, no. 3 (2000): 505–11.
Otero, R., et al. Snakebites and ethnobotany in the northwest region of Colombia. Part III. Neutralization of the haemorrhagic effect of Bothrops atrox venom. J Ethnopharmacol 73, no. 1–2 (2000): 233–41.
Oudhia, P. Khareti or bala (Sida cordifolia Linn.). Fact sheet on the website of the NewCROP program at Purdue University, 2004. http://www.hort.purdue.edu/newcrop/CropFactSheets/bala.html (accessed January 9, 2011).
———. Traditional medicinal knowledge about common herbs in Chattisgarh, India: interactions with the rice farmers of Tilda region. Research article on the website Botanical.com. http://botanical.com/site/column_poudhia/articles/_1130.html (accessed 11/20/2010).
———. Traditional medicinal uses of gangeran (Sida spinosa) in Chhattisgarh, India. Research article on the website Botanical.com. http://botanical.com/site/column_poudhia/articles/_1645.html (accessed November 20, 2010).
Prakash, A., et al. Alkaloid constituents of Sida acuta, S. humilis, S. rhombifolia and S. spinosa. Planta Med 43, no. 12 (1981): 384–88.
Rajakaruna, N., et al. Antimicrobial activity of plants collected from serpentine outcrops in Sri Lanka. Pharm Biol 40, no. 3 (2002): 235–44.
Rao, R. E., et al. Studies on fixed oil of seeds of Sida acuta Burm. J Am Oil Chem Soc 50, no. 5 (1973): 168–69.
Saganuwan, A. S., et al. Evaluation of Sida acuta subspecie acuta leaf/flower combination for antimicrobial activity and phytochemical constituents. Afr J Clin Exper Microbiol 7, no. 2 (2006): 83–88.
Sreedevi, C. D., et al. Hepatoprotective studies on Sida acuta Burm. f. J Ethnopharmacol 124, no. 2 (2009): 171–75.
Sutradhar, R. K., et al. Bioactive alkaloid from Sida cordifolia Linn. with analgesic and anti-inflammatory activities. Iran J Pharm Ther 5, no. 2 (2006): 175–78.
Williams, R., et al. A native growing season forage for wildlife—teaweed, Sida acuta Burm. f. Publication FOR 114, one of a series of the School of Forest Resources and Conservation, Florida Cooperative Extension Service, Institute of Food and Agricultural Sciences, University of Florida. First published December 2006; revised March 2011. http://edis.ifas.ufl.edu/pdffiles/FR/FR16800.pdf.
Chifiriuc, M. C., et al. In vitro study of the inhibitory activity of usnic acid on dental plaque biofilm. Roum Arch Microbiol Immunol 68, no. 4 (2009): 215–22.
Cocchietto, M., et al. A review of usnic acid, an interesting natural compound. Naturwissenschaften 89, no. 4 (2002): 137–46.
Doell, Janet. The saga of Usnea longissima in California. Bull Cal Lichen Soc 11, no. 2 (2004): 37–44.
Elo, H., et al. Potent activity of the lichen antibiotic (+)-usnic acid against clinical isolates of vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. Naturwissenschaften 94, no. 6 (2007): 465–68.
Esme, H., et al. Investigation of the germicidal effect of usnic acid, betadine, savlosol, and desderman on the protoscolexes of lung hydatid cysts. Tukiye Parazitol Derg 31, no. 2 (2007): 101–4.
Fazio, A. T., et al. Lichen secondary metabolites from the cultured lichen mycobionts of Teloschistes chryophthamus and Ramalina celastri and their antiviral activities. Z Naturforsch C 62, no. 7–8 (2007): 543–49.
Hariharan, G. N., et al. Checklist of lichens and lichenicolous fungi of Tamil Nadu (India). On the website of the Environmental Information System Centre, September 1, 2007. http://tnenvis.nic.in/Lichens/tamil-nadu.htm.
Ingólfsdóttir, K. Usnic acid. Phytochemistry 61, no. 7 (2002): 729–36.
Kim, M. S., et al. Melanogenesis inhibitory effects of methanolic extracts of Umbilicaria esculenta and Usnea longissima. J Microbiol 45, no. 6 (2007): 578–82.
Kreander, K., et al. A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin. Folia Micobiol 50, no. 6 (2005): 487–93.
Lans, C., et al. Ethnoveterinary medicines used for ruminants in British Columbia, Canada. J Ethnobiol Ethnomed 26, no. 3 (2007): 11.
Lauterwein, M., et al. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother 39, no. 11 (1995): 2541–43.
Lira, M. C., et al. In vitro uptake and antimycobacterial activity of liposomal usnic acid formulation. J Liposome Res 19, no. 1 (2009): 49–58.
Molnár, K., et al. Current results on biological activities of lichen secondary metabolites: a review. Z Naturforsch C 65, no. 3–4 (2010): 157–73.
Paranagama, P. A., et al. Heptaketides from Corynespora sp. inhibiting the cavern beard lichen, Usnea cavernosa: first report of metabolites of an endolichenic fungus. J Nat Prod 70 (2007): 1700–1705.
Paudel, B., et al. Antibacterial activities of ramlin, usnic acid and its three derivatives isolated from the Antarctic lichen Ramalina terebrata. Z Naturforsch C 65, no. 1–2 (2010)): 34–38.
Ramos, D. F., et al. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Pharm Biol 48, no. 3 (2010): 260–63.
Rawat, M. S. M., et al. Chemical study on Garhwal Himalayan lichen: Usnea emidotteries. Ind J Chem 45B (2006): 2566–70.
Rowe, J. G., et al. Antibacterial activity of some lichens from southern Spain. Ann Pharm Fr 47, no. 2 (1989): 89–94.
Storaunet, K. O., et al. Effect of logging on the threatened epiphytic lichen Usnea longissima: a comparative and retrospective approach. Silva Fennica 42, no. 5 (2008): 685.
Verma, N., et al. Antioxidant and hepatoprotective activity of a lichen Usnea ghattensis in vitro. Appl Biochem Biotechnol 152, no. 2–3 (2008): 167–81.
Vijayan, P., et al. Antiviral activity of medicinal plants of Nilgiris. Indian J Med Res 120, no. 1 (2004): 24–29.
Wang, X. P., et al. Plasmid elimination effect of usnic acid on the antibiotic-resistant Staphylococcus aureus. Zhong Yao Cai 29, no. 1 (2006): 36–39.
Weckesser, S., et al. Screening of plant extracts for antimicrobial activity against bacteria and yeasts with dermatological relevance. Phytomedicine 14, no. 7–8 (2007): 508–16.
Wei, L. L., et al. In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 26, no. 6 (2008): 438–41.
Yamamoto, Y., et al. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhabitation of tumor promoter-induced Epstein-Barr virus activation. Chem Pharm Bull (Tokyo) 43, no. 8 (1995): 1388–90.